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ABSTRACT 
 
 
Records of all neurosurgical inpatients admitted to Royal North Shore Hospital since 
1976 have been prospectively kept in a relational database.  Demographic details, 
diagnoses, operations and complications have been entered continuously since 
1982 by the author of this study.  Complications are monitored at monthly review 
meetings attended by medical staff.  The recurrence of deep vein thrombosis (DVT) 
and pulmonary embolism (PE) at these meetings, despite continual improvements 
in patient care, prompted this study.  It aims to use the database to study changes 
in the incidence of DVT and PE over the previous twenty years; to find what 
database variables predict these complications; and whether use of mechanical and 
pharmacological agents has had an impact on DVT and PE rate.  Univariate 
analysis of the incidence of DVT and PE by age, sex, length of stay (LOS), 
admission month, diagnosis, operation and surgeon over time was run.  Any 
significant variables were then analysed by multivariate logistic regression.  The 
DVT rate was low by world standards, but rose from 0.6% in 1979-83 to 1.2% in 
1984-88, then rose exponentially to 3.60% in 1994-98 with a significantly increasing 
trend over the twenty years (χ2 MH  =114.20, with IDF, P<0.001). PE rate doubled 
significantly over the twenty years from 0.6% to 1.2% (χ2 MH  =17.94 with 1DF, 
P<0.001).  Age, LOS, diagnosis, operation and surgeon were significant predictors 
of DVT and PE.  After adjustment for LOS, time period and age, vascular surgery 
was found to be the strongest predictor of DVT (OR=2.82, 95% CI: 2.08-3.82, χ2 
=43.91, P<0.01).  Vascular diagnosis was the strongest diagnosis predictor.  No 
effect of sex or month of admission was shown.  After adjustment for LOS, time 
period and age, spinal fusion was the strongest predictor of PE (OR=4.04, 95% CI: 
1.81-9.03).  Anterior communicating artery aneurysm was the diagnosis most highly 
associated with PE.  The rise in DVT rate may be due to increased complexity of 
surgical and nursing management, and some screening of patients with the 
introduction of duplex scanning.  The doubling of PE rate is unexplained.  The risk 
of brain or spinal cord haemorrhage makes prophylactic anticoagulation a difficult 
choice. This study reveals groupings which can be used to determine appropriate 
prophylaxis.  Use of mechanical and pharmaceutical agents is not recorded 
consistently in the database, but it is known approximately when they were 
introduced.  No impact on the rate of DVT and PE can be demonstrated by these 
agents.  More vigilant and widespread use of mechanical prophylaxis might be just 
as effective in controlling DVT and PE. 
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CHAPTER 1 - INTRODUCTION 
 
 
1.1   NEUROSURGICAL  CLINICAL  REVIEW  IN THE NORTHERN 
SYDNEY HEALTH AREA  
 
1.1.1  History of Database Setup 
 
In 1982 a relational database was begun, with the aim of recording details of every 
admission of patients under the care of the neurosurgeons at Royal North Shore 
Hospital (RNSH).  This would provide an easily accessible data collection for 
monitoring clinical or operative management, such as care of patients with rare 
conditions or new techniques like anterior cervical spinal interbody fusion, and to 
locate cases for teaching and research purposes.  
Admissions from 1976 until 1982 were added retrospectively; from 1982 data was 
added as soon as possible after the patient’s discharge from hospital.  
Retrospective data was taken from complete prospectively maintained admissions 
and operations registers, discharge summaries written by resident medical officers 
and neurosurgical registrars and operation reports dictated by the operating 
neurosurgeons, copies of which are still kept in the Neurosurgery Department.  
Where it was felt that complete data was not available from these sources, the 
medical record file for each admission was recalled for checking.   
 
It was felt that the ICD9 coding used by medical record departments was too 
cumbersome and confusing to add and to retrieve accurate and meaningful data.  
The emphasis was on a system which was easy to use and would provide 
consistent data over a long time.  After some years, and with the movement towards 
quality assurance it was decided to review patients’ complications regularly at 
monthly morbidity and mortality meetings to refine surgical practice.  This enabled 
validation by the surgeons of information entered in the database and provided a 
forum for peer review for the admitting surgeons, which is a requirement for their 
ongoing accreditation with the Royal Australasian College of Surgeons.  This 
validation has been continuous for the last ten years. 
The database now comprises a complete and confidential record of neurosurgical 
practice in RNSH, and contains 23,500 admissions. 
In 1996 a similar database was set up for patients admitted under the same 
neurosurgeons at Dalcross Private Hospital (DPH); this holds 3000 admissions; in 
1998 the same was commenced at North Shore Private Hospital (NSPH), and 
contains 950 admissions.  
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Originally Dbase III software was used, progressing to Informix run on an IBM PS2 
personal computer. Currently Access 97 is used on a laptop for the private hospitals 
and Access 97 on a networked PC at RNSH.  All the data has been entered by one 
person, the author, which confers consistency of data entry and management over 
the life of the database.  
Modern Neurosurgery is a young science, with the first operations performed by 
specialist neurosurgeons dating from the start of the twentieth century, although 
burr holes (trepanation) were performed as long ago as 3000BC.  Therefore, this 
database spans twenty percent of the lifetime of modern neurosurgery, a time when 
the specialty has undergone dramatic improvements brought about by the 
introduction of angiography, CT scanning, magnetic resonance imaging, 
microsurgery, and anaesthetic and intensive care advances.  Currently the rapid 
advances in endovascular procedures to obliterate intracranial vascular lesions and 
treat vasospasm are transforming the management of these conditions.   
 
1.1.2 Database Structure 
The structure of the database has remained the same since its inception.  Each 
inpatient episode or admission is given a unique number, which is the relational 
basis for the database’s five tables.  Each table contain demographic details, 
diagnoses, operations, complications and comments.  Data is recorded using four 
digit codes; diagnoses and operations are classed under neoplastic, vascular, 
traumatic, spinal, and other conditions.  Locations of tumours, aneurysms and 
spinal disorders are also coded.  Cranial tumour diagnoses differentiate between: 
low-grade astrocytoma 
high-grade astrocytoma 
meningioma 
pituitary tumour (subdivided according to histopathology) 
acoustic neuroma 
metastatic tumour 
recurrent tumour 
craniopharyngioma 
oligodendroglioma 
central nervous system lymphoma 
meningeal carcinomatosis 
pineal tumour 
ependymoma 
haemangioblastoma 
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medulloblastoma 
haemangioma 
osteoma 
colloid cyst 
other intracranial tumours. 
This somewhat idiosyncratic classification was adopted on the setting up of the 
database in 1982.  It was based on the classification used by the Royal Australasian 
College of Surgeons for its national surgical training audit.  It would render the 
database inconsistent and cause analytical problems to change the classification at 
some point in its time course. Classifications can change more than once. The 
author does not consider that it imposes any effect on the results of this study, 
however, because for the current analysis, all tumours are grouped together.   
Diagnostic and interventional radiological procedures have been recorded since 
August 1996.  Other fields, such as patient’s residential postcode, stay in the 
intensive care unit or use of thiopentone coma have been added as the need for 
these became apparent, or as these procedures were begun to be used.  Data was 
not added for every newest concept, but to add only codes for those felt to be of 
ongoing significance, to keep the database at a manageable size. 
  
1.1.3  Inclusion and exclusion criteria 
Inclusions 
The database maintains records for every patient either admitted under, discharged 
from the care of, or operated on by a neurosurgeon at RNSH.  Patients are not 
followed after discharge due to difficulties in maintaining contact and time restraints.  
A serious effort is made to ensure completeness of data by cross-checking entries 
from the patients’ medical record notes against daily, separate admission and 
discharge lists generated by the hospital’s computerised system, and against 
operation lists generated by the Anaesthetics Department at RNSH.  Operation 
booking lists and admission lists are used at DPH.  At NSPH a retrospective review 
of cases under neurosurgical care or operated by the neurosurgeons is requested 
and checked against the database which is based on admissions and operations 
selected by the IBA medical records database on a weekly basis. 
Exclusions 
1.  Patients admitted to the Spinal Injuries Unit of RNSH under a neurosurgeon but 
who did not have an operation, because these patients form a small proportion of 
the total and because management of this Unit is not under the supervision of 
the neurosurgeons. 
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2.  Patients seen only in the Emergency Department and not admitted to the 
hospital wards. 
3.  Patients admitted to and discharged from the wards within the same day without 
undergoing an operation.  
 
1.1.4  Morbidity and Mortality Review  
Every month, cases collected over that period are extracted from the database and 
a detailed report prepared, documenting number of admissions over that period and 
cases with complications listed individually. 
A meeting with all the neurosurgeons is held where complications are discussed by 
individual case and issues arising from them may be acted upon if feasible. 
The following complication flags are used in the neurosurgery review: 
Death 
Wound haematoma   
Wound infection   
Wound breakdown   
Meningitis   
Cerebrospinal fluid leak   
Unplanned return to the operating theatre 
Cerebral vasospasm   
Cerebral infarct shown radiologically     
Major deep vein thrombosis   
Minor deep vein thrombosis  
Pulmonary embolus  
Myocardial infarct        
Pneumonia   
Urinary tract infection   
Significant post operative neurological deficit 
Readmission with complication of a previous admission 
Vascular or other access complication 
Complication of radiological procedures 
Sepsis 
Unplanned return to Intensive Care Unit 
Miscellaneous complications. 
Strict criteria apply to each flag.  
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The databases are also used to extract information such as analysis of 
demographics, tumour types or operation types for other hospital staff.  Information 
from the databases is owned by the surgeons and is only provided with the 
permission of the surgeons involved. 
 
1.1.5  The Persistence of Deep Vein Thrombosis (DVT) and Pulmonary 
Embolus (PE) 
DVT, PE and death have been recorded consistently since the inception of the 
database.  DVT and PE are well-respected complications in hospital populations 
because DVT can arise insidiously and progress to PE and death in minutes in an 
otherwise seemingly well patient.  
 
At neurosurgical morbidity and mortality meetings, DVT and PE still present 
regularly, despite hospital protocols to minimise their incidence. The incidence of 
many other complications has declined over the same period, for example, wound 
infection and pneumonia.  This prompts the questions which comprise the aims of 
this study (Chapter 1.3):  
 
 How has the incidence of DVT and PE changed in the neurosurgical inpatient 
population in the twenty years since the beginning of the database?  
 Has the introduction of mechanical and pharmacological agents had an impact 
on the incidence of DVT and PE in this population?   
 What variables stored in the database and associated with patients’ admissions 
might predict the occurrence of DVT and/or PE? and 
 Does the database answer these questions? 
 
 
 
 
1.2  THE OUTCOME VARIABLES -  CAUSES AND MANAGEMENT OF DEEP 
VEIN THROMBOSIS AND PULMONARY EMBOLISM – 
                                     LITERATURE REVIEW 
 
Venous thrombosis is a common complication in hospital inpatients and outpatients.  
When located in the leg or pelvis it can progress to pulmonary embolism, 
sometimes fatal.  1% of all hospital admissions are found to die from PE (National 
Working Party on the Management and Prevention of Venous Thromboembolism 
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and Chronic Venous Insufficiency 1998).  Long term sequelae of venous thrombosis 
include venous insufficiency with the associated morbidity of chronic leg ulceration, 
which carries an incidence of 3-5% in the general population, and recurrent 
embolism, associated with pulmonary hypertension.  
1.2.1 Epidemiology 
The Incidence of DVT 
Once accurate methods for identifying DVT such as fibrinogen uptake test (FUT) 
were set up in the 1960s, the incidence in postoperative patients without 
prophylaxis was found to be greater than had been suspected (BERGQVIST 1994).  
Many studies worldwide tried to assess the incidence of DVT and PE in hospital 
populations, reporting a wide range, which made recommendations for prophylaxis 
and treatment difficult.  
Eventually, in 1986 the National Institutes of Health Consensus Statement ( 1986) 
was issued after a meeting of experts was held to characterise the problem of 
thromboembolism internationally and then to develop guidelines for prophylaxis.  
 
The more recent European Consensus Statement (Nicolaides et al. 1992) estimated 
the incidence of DVT in the general population as 160 per 100,000 per year or 
0.16%, and the rate of fatal PE as 0.06%.  Such figures are difficult to assess 
because of lack of consistent record-keeping.  The figures are based on death 
certificate returns in countries keeping centralised records, or on community-based 
studies.  Diagnostic criteria and inclusion/exclusion catchment issues are some 
weaknesses in such community-based studies.   
 
For postoperative patients without prophylaxis, in general surgery clinical DVT 
incidences of 16-30% and in orthopaedic surgery 35-57% per year have been 
quoted by many authors (Loxley et al. 1992) (Hull, Raskob, & Hirsh 1986). The high 
rates in orthopaedic surgery are associated with trauma to and immobilisation of a 
limb. In neurosurgical inpatients the actual incidence of DVT when measured by 
FUT has been stated as between 19 and 50% with no time period stated but an 
annual rate assumed (Hamilton, Hull, & Pineo 1994). 
 
16 to 100% of patients with spinal cord injury were found to have DVT measured by 
FUT, varying with degree of injury, presence of leg paralysis, and other risk factors 
(Hamilton, Hull, & Pineo 1994) and (Clagett & Reisch 1988). An annual rate is 
assumed.  
The Incidence of PE 
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This may be much higher than is clinically obvious.  Some writers (Sandler, Velchik, 
& Alavi 1988) found 13% of all in-hospital autopsies to have PE, but Clagett’s meta-
analysis (Clagett & Reisch 1988) notes symptomatic PE in 1.6% of postoperative 
patients.   
In general, orthopaedic and urology inpatients without prophylaxis, the incidence of 
post-operative non- fatal PE was 8-58%, detected by scintigraphy in the 1970s.   
After general surgery the incidence of post-operative fatal PE is reported to be 0.5-
7% (Sigel, Ipsen, & Felix, Jr. 1974); after orthopaedic surgery the incidence of post-
operative fatal PE is reported as 9-50% (Watson 1974) and the incidence of post-
operative fatal PE in neurosurgery is reported as 9-50% (Hamilton, Hull, & Pineo 
1994).  In spinal cord injury patients the incidence of post-operative fatal PE was 2-
16% (Naso 1974), (di Ricco et al. 1984).  Variability in the ranges quoted above is 
because of the variety of methods used to diagnose DVT and PE as well as the 
type of surgery, anaesthetic, period of in-hospital immobility and quality of pre- and 
post-operative care.  Another variable is the length of follow up- (Huber et al. 1992) 
noted a 30% increase in the rate of postoperative PE when PE after discharge is 
included in figures; but many authors have much shorter times of surveillance. More 
up-to-date incidences of PE and DVT in patients without prophylaxis are hard to 
obtain.  This is because it is now considered ethically unsound not to give protection 
against DVT (and hence some cases of PE), since it is known that most DVT cases 
can be prevented by prophylactic low molecular weight heparin (LMWH). 
  8
1.2.2 Natural History of DVT and PE 
 
The anatomy of the leg veins is shown in this diagram adapted from Way, 1983,  
p. 733. 
Fig. 1.2.2  The anatomy of the leg veins 
 
Venous thrombosis in superficial veins such as the greater saphenous does not 
generally progress and lyses without incident.  Deep venous thrombosis commonly 
arises in the calf veins such as the soleal sinuses and peroneal veins, where blood 
flow is static in supine immobile limbs. Patients with these thrombi only are not 
considered to be at great risk of pulmonary embolism; only 1% of patients with calf 
vein thrombosis will progress to PE and require treatment for their thrombosis (Hull 
et al. 1985).   If, however, thrombi propagate up the venous system into the 
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popliteal and femoral (proximal) veins of the leg, thence to the iliac veins and the 
inferior vena cava to embolise the pulmonary vessels, PE results.  20% of calf vein 
clots progress to the proximal leg veins, where they are more likely to go on to form 
a PE (Nicolaides & Kalodiki 1992).   
 
1.2.3  Pathophysiology 
Normal Clotting – A Simplified Description 
Thrombosis can arise without any known cause, but may be initiated by injury to a 
blood vessel wall.  Integrity of the inner endothelial venous layer of the vessel wall is 
important in maintenance of a healthy clotting system. Breach of the wall, by 
surgery or trauma, with resultant exposure of subendothelial collagen, causes a 
chain of events resulting in formation of a platelet plug.  This activates and is 
involved with a secondary haemostasis, the coagulation cascade, involving multiple 
biochemical factor interactions by an intrinsic mechanism.  This clotting cascade 
can also be started by an extrinsic mechanism to form thrombin, which enables 
creation of fibrin which also creates a haemostatic plug.  
  10
Normal clotting is summarised as follows- (adapted from Way, 1983, p.732).  
 
Fig 1.2.3.1 – Factors Involved in the Arrest of Haemorrhage 
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Abnormal clotting such as venous thrombosis. 
 
In 1856 Virchow identified a triad of factors involved in venous thrombosis- 
1. VENOSTASIS (disturbed blood flow). Gibbs (1957) (quoted in Bergqvist p32) 
showed in autopsies that venous thrombosis originates largely in the soleal sinuses 
of the leg.  The distal veins are the most common sites of thrombus initiation, even 
though any surgery may be at another site.  Comerota (quoted in Bergqvist p 40) 
showed that venostasis occurs during operation and he suggested that this is the 
effect of vasoactive amines on soft tissue released during trauma. Venous stasis 
occurs especially during total hip replacement; Comerota postulated that the vein 
wall stretches near valve cusps causing Virchow’s second factor, 
Vessel injury 
Coagulation activation- 
Extrinsic        Intrinsic 
 pathway        pathway 
Vasoconstriction Platelet  
adhesion 
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2. ENDOTHELIAL DAMAGE.  Injury to or stretching of a vein wall exposes 
thrombogenic subendothelial collagen such as occurs in surgery. 
3. HYPERCOAGULABILITY.  Venous thromboembolism does not occur without an 
underlying hypercoagulable state. Patients can have a variety of abnormalities of 
the fibrinolytic system which can predispose them to hypercoagulability.  There are 
usually multiple factors at work, of two types:  
Inherited - the minority of patients, e.g. those with deficiency of natural inhibitors of 
coagulation such as Protein C, Protein S, antithrombin III; those with disorders of 
fibrinolytic system such as fibrinolytic activators and inhibitors of vascular damage. 
Acquired -these are associated with carcinoma, use of oral contraceptives, 
disorders of protein metabolism including liver disease; with lupus erythematosis, 
ulcerative colitis and platelet disorders.  
The interactions of factors contributing to DVT have been set out as follows (Agu, 
Hamilton, & Baker 1999): 
 
Fig. 1.2.3.2 – Processes involved in formation of DVT 
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1.2.4  Risk Factors for Thromboembolism 
It is well known that DVT and PE are associated with trauma, orthopaedic, 
abdominal and thoracic surgery.  Lengthy surgery is associated with much higher 
risk (Huber, Bounameaux, Borst, & Rohner 1992) and general - as opposed to 
spinal/epidural – anaesthesia (Modig et al. 1981),  (McKenzie et al. 1985).  Other 
factors predisposing to DVT and PE include age, associated with decreasing 
venous tone, obesity, pregnancy, hormone use and previous venous 
thromboembolism.  Sepsis, cardiac and neurological disease are also implicated; 
Ç venous    
    dilatation    
È flow    
velocity 
 È valve 
function 
È extrinsic 
pathway 
inhibitor
Ç tears of 
endothelial lining 
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the paralysed insensate limb of a stroke patient can be subject to pooling of blood, 
loss of venous tone, or accidental trauma.  Malignancy, supratentorial intracranial 
surgery, and differences in care such as type of mattress and length of 
immobilisation are additional factors.  Even seasonal/circadian rhythm has been 
linked to fatal PE (Lawrence et al. 1977).  At several consensus conferences since 
1986 ( 1986), (Nicolaides, Arcelus, Belcaro, Bergqvist, Borris, Buller, Caprini, 
Christopoulos, Clarke-Pearson, & Clement 1992), there has been broad agreement 
that neurosurgical patients with lower limb paralysis and paraplegic patients should 
be designated at high-risk of thromboembolism.  Patients with head injury, 
intracranial tumour and subarachnoid haemorrhage were considered to be at 
moderate risk.   
 
1.2.5  Diagnosis of DVT 
Accurate diagnosis is important to enable patients with DVT to be treated so that 
potentially fatal PE is averted, and to minimise the chance of sequelae such as 
post-phlebitic syndrome.   
Pain and swelling of the leg may indicate the presence of DVT, but diagnosis based 
on clinical findings alone is not reliable because of the numbers of cases of silent 
DVT showing no clinical symptoms or signs. In stroke or spinal cord injury patients 
with paralysed limbs, DVT may be hard to recognise because limbs may be swollen 
already, and an unconscious patient is not able to complain of leg pain. The first 
manifestation of such asymptomatic DVT may be that of a fatal PE.  
Venography is still the gold standard diagnostic test.  It is accurate but invasive.  
Intravenous (IV) radiological contrast agents may cause side effects and it is 
inconvenient to repeat venography often for monitoring purposes. 
Impedance plethysmography is insensitive to calf vein thrombosis, but has high 
sensitivity for proximal vein thrombosis.  
Fibrinogen uptake test (FUT)- radioactive fibrinogen shows the development of clots 
in the legs, but does not find clots in the proximal veins, which are the ones 
progressing to form PE.    
B-mode ultrasonography (White et al. 1989). This is a non-invasive test, can be 
used for screening, and has a high sensitivity and specificity for symptomatic 
proximal DVT. 
Screening for DVT may be an attempt to control the incidence of PE but until 
recently a non-invasive, cost effective, sensitive and reliable method had not been 
found.  
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Duplex scanning now satisfies these criteria.  It combines ultrasound with Doppler 
(haemodynamic colour flow imaging) to allow visualisation of smaller veins. White’s 
study (White, McGahan, Daschbach, & Hartling 1989) showed that Duplex scanning 
located all above knee and 78% below knee DVT. It has been found to have high 
sensitivity and specificity when compared to venography.  Duplex scanning has 
been used at RNSH for some screening and monitoring of DVT since 1991.   
 
1.2.6  Diagnosis of PE 
PE may arise without symptoms, making clinical diagnosis difficult.  When 
symptoms are evident, they can include shortness of breath, pleuritic chest pain, 
sweating, cough, leg swelling and pain.  Tests for PE include- 
Pulmonary angiography is the gold standard test for PE, but has the same 
drawbacks as venography as it uses IV injections of radiological contrast. 
Ventilation Perfusion (V/Q) scans measure uptake of radiolabelled albumin to see 
abnormal pulmonary blood flow and these are compared with a ventilation scan of 
labelled inhaled gas.  Scans are reported as low, intermediate or high probability for 
PE, but prospective studies show that 25-40% patients with low probability scans 
revealed PE on subsequent pulmonary angiography (Hull et al 1985).    
Diagnosis of PE at RNSH has been by V/Q scanning for at least ten years.  RNSH 
patients with a low-probability V/Q scan but with clinical symptoms of PE are now 
screened with spiral pulmonary angiography. 
 
1.2.7  Prophylaxis against DVT and  PE  
Because PE is a widespread cause of preventable death in inpatients, prophylaxis 
against DVT is important, to minimise both the costs of treatment of DVT and PE 
and the impact of their complications.  Many PEs originate from proximal DVT and 
can be prevented by anticoagulation when DVT is diagnosed.  Proper diagnosis and 
treatment of PE is now associated with a death rate of 2%, compared with 
estimates of 30% for patients with undiagnosed PE (Dalen & Alpert 1975). However 
diagnosis of PE is not always easy and the side effects of anticoagulation make it 
too hazardous to administer without a firm diagnosis of PE or DVT. 
Neurosurgical patients pose special management problems because of the risk of 
intracranial or spinal cord haemorrhage with anticoagulants, hence the caution 
traditionally used by neurosurgeons with pharmacological prophylaxis for DVT.  
There are several types of prophylaxis  against DVT– 
a) Mechanical, which aim to reduce venous blood stasis in the legs. 
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Electrical calf stimulators have been used in the operating room while the legs are 
immobilised- this is a non-invasive technique and is relatively inexpensive.  It was 
used in the past at RNSH but has been replaced for moderate and high-risk patients 
by - 
Intermittent pneumatic calf compression, also known as sequential compression 
devices (SCDs) using disposable or washable leg sleeves, are relatively 
inexpensive.  Some practitioners feel that the full thigh-length models are the only 
effective ones.  They are not suitable for ambulatory patients.  Turpie has 
demonstrated its effectiveness (Turpie et al. 1977). 
Elastic graduated support (compression) stockings were found to be effective 
against venous thrombosis by Turpie (Turpie et al. 1989). They are less awkward 
than calf compressors as patients can mobilise while wearing them. They are well 
tolerated by patients, can be used after discharge from hospital, are cheap and 
safe.  However, evidence on prevention of fatal PE with their use is still not 
conclusive.  
Vena Caval filters are inserted under radiological control, and are designed to 
prevent clots already diagnosed in the leg from progressing to PE.  They are useful 
prophylaxis for patients in whom anticoagulation is contraindicated, but are not 
prophylactic against DVT. 
b) Pharmacological 
Low dose heparin has been shown to be effective in reducing DVT in general 
surgical patients (Clagett & Reisch 1988), (Collins et al. 1988). 
Low molecular weight heparins (LMWH) (e.g “Clexane”, “Fragmin”) are recently 
developed drugs used for neurosurgery patients since 1991 (Voth D 1992).  There 
appear to be fewer haemorrhagic side effects with the LMWHs than with standard 
heparin, making them more appealing to neurosurgeons, but they are more 
expensive than heparin. They are increasingly being used by neurosurgeons. The 
RNSH Department of Neurosurgery has used Fragmin since 1992 if required by the 
consultant, and Clexane was included in the protocol for post-operative 
management of spinal surgery patients. 
 
Antiplatelet drugs.  In 1992 the role of antiplatelet agents like aspirin seemed 
uncertain and at any rate not as effective as LMWH. These compounds are 
effective orally, are relatively free of side effects and inexpensive, but their effect on 
platelets does not translate to a potent antithrombotic effect.   
Cost effectiveness.  Prophylaxis with LMWH or low dose heparin is cost effective 
(Hauch, Khattar, & Jorgensen 1991).  Hauch’s results suggest LMWH is better than 
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low dose heparin in general surgery, and standard heparin dihydroergotamine 
(DHE) is better than LMWH in elective hip replacement. However, in neurosurgical 
patients prophylaxis with anticoagulants is difficult because of the chance of 
bleeding.  In fact, the European Consensus Statement (Nicolaides, Arcelus, 
Belcaro, Bergqvist, Borris, Buller, Caprini, Christopoulos, Clarke-Pearson, & 
Clement 1992) suggested only mechanical prophylaxis for neurosurgical patients. 
Nursing care - early post-operative mobilisation is now recognised as an important 
part of care for many postoperative patients. 
 
Prophylaxis in neurosurgery patients.   
In the 1970s patients at risk were given elastic support stockings and/or calf 
stimulation during surgery, but neurosurgery patients were not often given 
anticoagulants. Following the success of the introduction of low-dose heparin as 
prophylaxis in other surgical specialties during the 1970s, the rate of post operative 
DVT in neurosurgical patients treated with heparin (Cerrato, Ariano, & Fiacchino 
1978) fell from 34% to 6%.  These authors, however, did not mention the rate of PE 
in these patients. Clagett’s meta-analysis (Clagett & Reisch 1988) reported 
symptomatic PE reduction by 2/3 with subcutaneous low dose heparin. 
External pneumatic leg compressors were shown to improve the effect of heparin 
against DVT in a review (Swann & Black 1984), but the incidence of PE in these 
patients had not fallen with these measures.  A review (Powers & Edwards 1982) 
found that the numbers in low-dose heparin studies were too small to measure any 
bleeding complications. Others (Bostrom et al. 1986) showed a protective effect of 
calf muscle stimulation plus postoperative Dextran and also of low-dose heparin 
when compared with controls given no prophylaxis. Peroperative calf compression 
was found to be protective against DVT (Bynke, Hillman, & Lassvik 1987), and in a 
randomised controlled trial (Turpie, Hirsh, Gent, Julian, & Johnson 1989), a fall of 
DVT to 9% , from 20% in the untreated control group was observed in “potential” 
neurosurgical patients treated with compression stockings plus pneumatic 
compression.  Others (Flinn et al. 1989) reported prospective surveillance with 
duplex scanning plus elastic stockings and intermittent calf compression to minimise 
venous stasis in 361 patients undergoing major neurosurgical procedures, with a 
DVT incidence of 4.7%.  Frim et al (1992) claimed success with post operative 
heparin and intraoperative pneumatic compression in neurosurgical patients (rate 
0%) compared with intra- and post operative compression alone (rate 3.2% DVT 
and PE).  Studies were reporting the use of low molecular weight heparins (LMWH) 
by 1990 (Kakkar & Stringer 1990); Flinn et al. (1996) showed a low incidence of 
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fatal PE of 0.07%, supporting a duplex screening and mechanical prophylaxis 
program as reported above.  Use of LMWH increased the protection given by 
mechanical devices and is recommended for high-risk patients (Agu, Hamilton, & 
Baker 1999) but increased the incidence of postoperative intracranial haemorrhage 
in brain tumour patients (Dickinson et al. 1998).  Thus, currently compression 
stockings and calf stimulators are still used, maybe along with low molecular weight 
heparins such as Clexane or Fragmin. 
The current prophylaxis recommended at RNS for high-risk patients (most 
neurosurgery patients) is subcutaneous unfractionated heparin or LMWH plus calf 
compressors or calf stimulators, commencing pre-operatively and continued for 5-7 
days or until the patient is mobilised.  However prophylaxis has been conducted on 
an individual patient basis because of concerns about post operative haemorrhage 
in the brain or spinal cord.  Compression stockings are to be used as required for 
patients with prolonged immobility or persistent swelling.  Calf compressors are now 
used in the operating room for cases lasting more than three hours, although some 
practitioners consider that they are not firm or long enough to be effective.  All 
patients on the general neurosurgical ward, including those waiting for surgery, are 
required to wear graduated compression stockings.  These are freely available, but 
it is difficult to achieve 100% compliance with their use, as patients often roll them 
down or remove them, and nurses may be too busy to be vigilant about their use.  
Patients are given LMWH prophylactically according to clinical judgement, and 
those having vascular surgery are required to have a screening duplex scan seven 
days post operatively or if calf tenderness develops (Department of Haematology 
1998).   
 
1.2.8  Treatment of DVT and PE 
Thrombolytic agents such as Streptokinase (SK), Urokinase (UK) and Tissue 
Plasminogen Activator (TPA).  Their role remains controversial, they are not used 
routinely in RNSH, except in special cases for the treatment of PE.  Their use 
carries a real risk of haemorrhage.  
Warfarin, an oral anticoagulant, inhibits the action of Vitamin K on the manufacture 
of clotting factors in the liver. Its action is not fully apparent until 1-3 days after 
administration.  
Oral anticoagulants also inhibit the vitamin K-dependent synthesis of Protein C, a 
precursor of activated Protein C, an inhibitor of activated factors V and VIII of the 
clotting cascade.  Warfarin doses are adjusted to achieve maximum anticoagulant 
activity with minimum risk of bleeding, by monitoring the patient’s prothrombin time, 
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which is expressed as the International Normalised Ratio (INR) and is the 
prothrombin time measured against World Health Organisation standard 
thromboplastin.  
Standard unfractionated heparin has an immediate effect when given IV.  Because 
of the variable anticoagulant response in patients, this must be monitored.  It is thus 
an expensive and labour-intensive form of treatment.  
IV infusion of heparin and concurrent oral Warfarin.  Heparin is weaned after the 
patient is warfarinised. 
LMWH.  Patients can be discharged earlier when treated with LMWH because they 
need only two injections per day and no laboratory monitoring of their anticoagulant 
response. 
Filters inserted under radiological control into the inferior vena cava to prevent 
passage of a leg thrombus into the lung are used for patients with recurrent 
thromboembolism or in whom anticoagulation would be risky, e.g. neurosurgery 
patients who have suffered an intracranial haemorrhage.  Effectiveness and safety 
of these devices, although they have been available for about twenty years, is not 
well known because there are no prospective randomised clinical trials reported.  
The Greenfield filter has become the design of choice as it permits maximum 
capture of clots while allowing maximum blood flow.   
DVT and PE, once identified, were anticoagulated at RNSH in the late 1970s with 
heparin and warfarin, or if that was not possible, filters were inserted into the inferior 
vena cava. 
Current treatment at RNS (Department of Haematology 1998) for DVT is 
subcutaneous LMWH or IV unfractionated heparin given for 1-2 days then 
subcutaneous LMWH or continued IV heparin with laboratory monitoring.  
Prophylaxis for PE is IV unfractionated heparin, weaning to Warfarin.  For massive 
PE, surgery involving pulmonary embolectomy is possible, or the recommended 
thrombolytic therapy UK, SK or TPA.  
It is not known how well these guidelines have been followed in the past or at 
present, although a culture of “best practice” has always prevailed at RNSH, a well-
respected teaching hospital. 
A scan of Neurosurgery Department records shows that duplex scanning was used 
for diagnosis of some DVT at RNSH from 1991, while the LMWHs Fragmin and 
Clexane were used selectively for treatment of DVT from 1992. The author is aware 
of at least five cases of haemorrhage into wound sites after use of LMWHs.  
 
1.2.9  Costs 
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The best approach to managing DVT and PE is one which provides the best 
outcome for patients at the minimum expense to society.  Little information is 
available on costs in Australia currently, except that the cost of an injection of 
LMWH is between $7 and $8.50, while an injection of Calcium Heparin is about 
$2.00.  However, Hull (Hull et al. 1995) found non-invasive testing using IPG and B-
mode ultrasonography more cost effective in “appropriately chosen patients” than 
clinical diagnosis or venography in 1992 Canadian or US dollars. Another study 
(Velmahos et al. 2000) in the US used evidence-based studies to set up a cost 
effectiveness model and concluded that low-dose heparin is more cost-effective 
than LMWH or SCDs in prophylaxis against thromboembolism. 
Management of patients as outpatients, if possible, is cheaper, making LMWH, 
although a more expensive drug, preferable to heparin, which requires expensive 
laboratory monitoring and an inpatient stay.  Subcutaneous LMWH enables this, 
however poor patient compliance at home could be a problem in this case.  LMWH 
has the added advantage that the patient can be mobile.  By treating DVT on an 
outpatient basis, it has been estimated that 5-6 days would be saved per patient 
episode, amounting to $500 million in the US in 1986 (Rooke & Osmundson 1986).  
 
1.3 Aims 
This study attempts to answer the following questions: 
• What are the incidences of DVT and PE in neurosurgical patients at RNSH? 
• Have the incidences of DVT and PE changed over the last twenty years? 
• Can any variables recorded with patient admissions in the database be shown 
to predict the incidence of DVT and PE? 
• Can it be shown that the introduction of mechanical and pharmacological 
treatments over the last twenty years has changed the rate of DVT and PE? 
• Has the database been shown to be a useful tool for such an epidemiological 
study? 
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CHAPTER 2 - METHODS 
2.1 - DATA VALIDATION  
The database tables of admissions, diagnoses, operations, complications and comments for 
admissions from May 1976 until September 1999 were examined for accuracy and 
completeness.  All fields were sorted by ascending data to find any suspiciously outlying values, 
which were checked against original documents, for example a length of stay of 530 days.  
Individual admission dates were checked as being earlier than discharge dates.  Missing data was 
entered from the original documents.  138 known such errors were detected and repaired.  
Cases with DVT or PE were checked against their comment fields to confirm their status, and 
investigated for a death coding.  Morbidity and Mortality meeting reports for the last ten years 
were reviewed for any further information.   An incidental audit of records of patients receiving 
thiopentone coma with another hospital department revealed perfect agreement.  At the end of 
this procedure there was no obviously missing data.  It is estimated that about 500 admissions 
within the inclusion criteria were not added to the database during the 23-year period because 
their medical record notes were not available.     
 
2.2  INCLUSION AND EXCLUSION CRITERIA  
2.2.1  Database criteria for DVT:   
The study is about DVT and PE which are documented and recognised on clinical grounds.  It 
includes new thromboses in soleal sinusoids, peroneal, femoral, iliac, popliteal, gastrocnemius, 
posterior tibial, IVC, pelvic or axillary veins, documented by venography or duplex scan 
(Doppler + ultrasound).  Thromboses in any of these locations was included, even though some 
sites are regarded as more serious than others, because of the nature of DVT evolution over the 
course of an admission and because of difficulty in recording locations and size of DVT in the 
early years of the database due to methodological limitations.  DVT on admission was excluded, 
even if this was a readmission with DVT after a previous neurosurgical admission, because not 
all DVTs arising after discharge would be admitted to the same hospital or under the care of a 
neurosurgeon, making it difficult to find these cases.  The study cannot include “silent” DVT, 
even though these may exist in patients with PE. 
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2.2.2  Database criteria for PE:  
High probability of PE documented on VQ scan; or intermediate probability of PE documented 
on VQ scan plus clinical symptoms such as chest pain, shortness of breath, respiratory alkalosis 
(hypoxia & hypocapnia). 
From the validated data set, initially cut-off points were chosen to include discharges for the 23-
year period from 1/10/76 to 30/9/99 so as to include as many complete years as possible for 
analysis.   
 
2.3  PRELIMINARY EXPLORATION OF DVT AND PE DISTRIBUTION 
2.3.1  Incidence of DVT, PE and death over time 
Variables recorded in the database which may help to predict DVT and PE were systematically 
analysed to determine their relationship to the incidence of DVT and PE.  Variables available 
for the whole period of the database were age, sex admitting surgeon, admission and discharge 
dates, diagnosis, operation and complications.  First, using Microsoft Access queries and 
Microsoft Excel, descriptive statistics were prepared for incidence of DVT, PE and death in the 
entire database and displayed in table (3.1) and graph (Fig 3.1.1) form over time. Incidence was 
calculated as follows: 
  
Incidence of DVT, PE or death per discharge over time = 
          discharges with DVT, PE or death in a period (n) x 100 
     total discharges in that period (n) 
The observation of a fall in death rate over time prompted a breakdown of death rate according 
to diagnostic group to see if any particular group contributed more to this (Table 3.1.1). 
 
2.3.2  Statistical confirmation of trends 
To confirm the impressions gained from Fig. 3.1.1, patient discharges were divided into four 
groups spanning five years each.  The earliest discharges, from May 1976 to December 31 1978, 
were not included so that groups could span equal periods and for ease of analysis.  The four 
groups including discharges dated from 1/1/1979 to 31/12/1998 are collectively referred to in 
this treatise as “the population under study”.  
Analyses were run in Minitab for χ² test statistics to determine any significant differences 
between groups, and in SAS for Mantel-Haenszel χ² values to test for trend across the DVT 
and PE groups. 
One-way analysis of variance using unstacked data in Minitab was used to compare group 
averages. 
Distribution of DVT, PE and death from all causes in the population under study were 
calculated and are displayed in Table 3.1.2. 
 
2.4  EXPLORATION OF POTENTIAL PREDICTORS OF DVT AND PE   
Means and proportions of age, sex, length of stay and operative status in the four five-year 
periods are shown in Table 3.2.1 with relevant test statistics to determine whether the 
distribution of these basic potential predictors changed over the period 1979 to 1998.  The 
distribution of DVT and PE according to potential predictors was then further explored as 
below.  Death was no longer included in the analysis because its relationship to DVT and PE in 
this database is not known. 
 
2.4.1.  Incidence of DVT and PE by age 
Age was chosen as a potential predictor of DVT and PE because it is known to affect many 
health outcomes.  Initially, incidences of DVT and PE were plotted from the entire database of 
discharges against their age (Fig 3.2.2) by age using a similar formula to that in Chapter 2.3.1.  
For analysis in the five-year periods, age groups were set at 0-29, 30-44, 45-59, 60-74 and 75+ 
years.  Distribution of DVT and PE were calculated over each of the four five-year discharge 
periods, with χ2 measures to test for significant differences between age groups within each 
period and between periods across the age groups (Tables 3.2.2.1, 3.2.2.3).  χ2  test statistics were 
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also obtained for the age groups across the period of the population under study, 1979-98.  
Results are shown in 3.2.2.2 and 3.2.2.4.  
 
2.4.2  Incidence of DVT and PE by sex 
Sex was chosen as a variable in this study because it can be a determinant in many health 
outcomes.  
DVT and PE rates with χ2   test statistics were calculated for each sex (Table 3.2.3).  Rates 
broken down into periods are shown in Table 3.2.3.1.  
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2.4.3  Incidence of DVT and PE by month 
Because we have noted clusters of DVT and PE in our regular Morbidity and Mortality 
meetings, and reports of fluctuations in the rate of PE with season in the literature (Agu, 
Hamilton, & Baker 1999), a graph was prepared (Fig. 3.2.4) to show their seasonal distribution 
using a similar formula to that in Chap 2.3.1.  Another analysis of DVT and PE was run by 
admission month in a similar way (Fig 3.2.5), because the onset of DVT and PE in hospital may 
have a stronger relationship in time to admission date than discharge date because of the varying 
lengths of hospital stay. Predictive factors such as age and sex, analysed here by discharge date, 
remain relatively constant for a hospital stay. 
Because of the pattern seen in this graph, cases with DVT and PE grouped by admission month 
were analysed in Minitab to confirm any differences in incidence between the months.  Results 
are shown in Chapter 3.2.4. 
 
2.4.4  Incidence of DVT and PE by length of hospital stay (LOS): 
 Length of stay is likely to be a predictor of DVT and PE because prolonged immobilisation in 
bed of susceptible patients with stasis of blood in the limbs will favour the formation of 
thromboembolism.  
 LOS = [ Discharge date] - [admission date] in days.   
A preliminary graph of DVT and PE incidence according to LOS and distribution of DVT and 
PE by LOS over the four five-year periods were prepared (Chapter 3.2.5) using a formula 
similar to that in Chap. 2.3.1. 
 
2.4.5  Incidence of DVT and PE by diagnosis  
Diagnostic groups were defined as in the database table of diagnoses, i.e, tumour (not spinal), 
vascular (not spinal), trauma (not spinal), spinal (including spinal tumours, vascular 
malformations and trauma).  Some diagnoses such as brain abscess, trigeminal neuralgia and 
peripheral nerve conditions do not fit into these categories and were placed in a group named 
“Other”.  Counts were obtained for the first four groups and the total using Access queries, and 
for “Other” by subtraction of the first four groups from the total.  Where cases were included in 
two or more groups, they were reviewed individually and classified into just one group, taking 
account of the operations performed and comments recorded in the Comments table.  For 
example, if a patient was admitted for management of a tumour, but suffered a subarachnoid 
haemorrhage during operation for the tumour with consequent prolonged hospital stay and 
increased morbidity, that patient would be classified as vascular, not tumour. 
The distribution of diagnostic groups was examined in the four five-year groups, then 
distribution of DVT and PE by diagnostic group was calculated across the five-year groups 
(Chapter 3.2.6). 
 
2.4.6  Incidence of DVT and PE by surgical group 
The literature reports wide variation in the incidence of DVT and PE in different 
surgical groups, with orthopaedic surgery tending to be highest.  Some spinal 
operations in our Neurosurgery database would be classified as orthopaedic, 
whereas the minor peripheral nerve operations would be considered to have low 
incidence of DVT and PE.  As was done with diagnostic groups, distribution of all 
discharges in the four five-year groups by type of surgery was calculated (Chapter 
3.2.7).  This grouping was created because patients with a particular diagnosis may 
have several treatment options.  For example, a patient with a cerebral aneurysm 
could have endovascular treatment in the radiology department, no surgery, or a 
surgical repair. Thus the diagnostic and surgical groups are not identical.  The 
literature suggests that surgery is a contributor to thrombogenesis, therefore 
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patients without surgery are at less risk of DVT or PE. Surgery groups were defined 
as in the database table of operations, i.e. operations for brain tumour (not spinal), 
vascular conditions (not spinal), trauma (not spinal), spinal conditions (including 
spinal tumours, spinal vascular conditions and spinal trauma). The proportions of 
spinal tumours and vascular conditions in the spinal group would be small. Any 
other operations, such as peripheral nerve operations, were classified as “other”.  
Thirty cases were coded for two or more groups. They were reviewed individually, 
taking account of all the information available.  For example, where a patient 
underwent excision of a tumour and of a haematoma from that tumour, the case 
was classified as “tumour” because the admission was for management of the 
tumour.  It was assumed that the effects of haemorrhage did not over-ride the 
tumour classification.  If a patient was coded for an “Other” classification and 
another classification, the “Other” classification was over-ridden.  “The “No surgery” 
group may include patients who had endovascular procedures in the radiology 
department but did not go to the operating room during their admission.  Distribution 
of DVT and PE in the surgical groups across the five-year periods was calculated 
and is shown in Tables 3.2.7.2 and 3.2.7.3. 
 
2.4.7  Incidence of DVT and PE by admitting surgeon 
Another variable recorded in the database and an obvious one to be considered in this analysis 
is the surgeon responsible for the patient’s care while in hospital.  This surgeon is also most 
likely to be the operating surgeon if the patient goes to theatre, if only in a supervisory capacity.  
Surgeons 1 and 2 were well established in their practices at the beginning of the database in 
1976, and retired during the period of the database.  Surgeons 3, 4, 5, 6 and 7 commenced 
practice during the database period and are still in practice. Where a patient was transferred 
from the care of one surgeon to another, the surgeon who performed any operation was 
allocated to that discharge.  Some overlap between surgeon, diagnostic group and surgical group 
exists, but this is not easy to measure.   
Graphs were made showing the distribution of DVT and PE by year for the individual surgeons 
(Figs 3.2.8.1. and 3.2.8.2). Distribution of diagnostic group according to surgeon was calculated 
for all discharges in the database 1979 to 1998, then DVT and PE by surgeon for the same 
period, in the same manner as for incidence of DVT and PE by diagnosis.  Incidences were 
calculated as in Chap. 2.3.1. 
 
2.4.8 SUMMARY   
χ2 values for the univariate analyses of potential predictors of DVT and PE as described in the 
preceding Chapter 2.4 were summarised in Table 3.3.1.  As the univariate analyses showed 
several variables have a marked association with DVT and PE rates, a multivariate logistic 
regression analysis was carried out to disentangle their effects.   
2.5  FURTHER EXPLORATION OF PREDICTORS OF DVT AND PE USING 
MULTIVARIATE LOGISTIC REGRESSION 
2.5.1  Creation of Dataset for Logistic Regression 
Five fixed-width text tables were created via Access queries from the Neurosurgery database.  
They contained variables as follows: 
a) Neuro no. (the unique identifier), age, sex, vmo (surgeon), discharge date and LOS for each 
admission;  
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b) Neuro no. and DVT identifier for each admission with DVT; 
c) Neuro no. and PE identifier for each admission with PE; 
d) Neuro no. and diagnosis codes for each admission; 
e) Neuro no. and operation codes for each admission. 
These tables were loaded into Statistical Analysis System (SAS) v. 6.12, and 
merged by Neuro no. into one dataset.  
Age, discharge date and LOS were kept as continuous variables.  DVT, PE, sex, 
vmo, diagnostic group and surgical group were used as categorical variables. 
In order to correct the non-linearity for age seen in Fig. 3.2.2, a new categorical variable, 
“agegp”, was created, taking the value 1 where age ≥ 80 years, and 0 otherwise. 
To correct for the non-linearity for LOS seen in Fig. 3.2.5, a new categorical variable, “losgp”, 
was created, taking the value 1 for LOS is 80-89 days, 2 for LOS ≥ 90 days and 0 otherwise. 
To correct for the non-linearity for discharge date seen in Fig. 3.1.1, three new dummy variables 
for the four time periods were created: Period2 for discharge dates between 1/1/84 and 
31/12/88, Period3 for discharge dates between 1/1/89 and 31/12/93 and Period4 for 
discharge dates between 1/1/94 and 31/12/98. 
    
2.5.2 Logistic Regression Analysis 
Logistic regression models were run using the forward method of stepwise addition of variables 
to the model, retaining only variables which provided a significant contribution to the model. 
Sexgp was not included in the model as univariate analysis indicated an insignificant influence 
on the incidence of DVT or PE. The forward stepwise method was chosen because of expected 
collinearities between vmo, diagnostic groups and surgical groups.  A test for significance for 
variables added was obtained by subtracting the χ2 value and the degrees of freedom of the 
preceding model from those for the model with newly added variables. Significance levels were 
kept strictly to less than 0.01 or 1% for inclusion of variables in the model.  An odds ratio with 
95% confidence intervals is provided for each variable in the SAS printout for the regression 
analysis.  The model of best fit was chosen on the basis of the highest χ2 value, and for the 
addition of single (not dummy) variables, to a P value of <0.01. 
 
The following models were run for DVT: 
a) DVT as outcome variable with los, losgp, periods, age, agegp.   
Results are shown in Table 3.4.1.1. 
Vmo’s, diagnostic and operation groups were then placed in the model separately.   
Results can be seen in Tables 3.4.1.2. 
In order to determine whether diagnoses and operations predicted DVT more 
accurately individually rather than as groups, they were ranked in order of incidence 
of DVT (Tables 3.4.2, 3.4.3,). All diagnoses and operations are included in these 
tables for interest and comparisons, but only those recorded over the full twenty 
years will be evaluated in the following analyses. Further models were then run as 
follows:  
 
b )  DVT with its base model and the five individual diagnoses with the highest         
      incidences of DVT taken from Table 3.4.2, where only those diagnoses with      
      five or more cases were considered.  Results are shown in Table 3.4.2.1. 
c ) DVT with its base model and individual operations associated with the highest       
     incidences of DVT taken from Table 3.4.3, where only those operation groups    
     with five or more cases were considered.  Results are shown in Table 3.4.3.1. 
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Logistic regression analysis for PE was done the same way as for DVT. Diagnoses 
and operations from the database were ranked for incidence of PE (Tables 3.4.5 and 
3.4.6).  Models were run as follows: 
 
b) PE as outcome variable with vmo, diagnosis and operation groups as in a). Results are 
shown in Tables 3.4.4.1 and 3.4.4.2. 
c) PE with its base model and the five individual diagnoses associated with the highest 
incidences of PE taken from Table 3.4.5.  Only those diagnoses with five or more cases of 
PE were used in the analysis.  Results are shown in Table 3.4.5.1. 
d) PE with its base model and individual operations associated with the highest incidences of 
PE taken from Table 3.4.6.  Only those operations with five or more cases of PE were 
used.  Results are shown in Table 3.4.6.1. 
 
To summarise, effects of surgeon, diagnosis and operation on the incidence of DVT 
and PE adjusted for length of stay, period and age are given in Tables 3.4.6 and 
3.4.7. 
 
  
 
 
References 
 
 1.   1986, "Prevention of venous thrombosis and pulmonary embolism. NIH 
Consensus Development", JAMA, vol. 256,no. 6, pp. 744-749. 
 2.  Agu, O., Hamilton, G., & Baker, D. 1999, "Graduated compression 
stockings in the prevention of venous thromboembolism", Br.J.Surg., 
vol. 86,no. 8, pp. 992-1004. 
 3.  Bostrom, S., Holmgren, E., Jonsson, O., Lindberg, S., Lindstrom, B., 
Winso, I., & Zachrisson, B. 1986, "Post-operative thromboembolism in 
neurosurgery. A study on the prophylactic effect of calf muscle 
stimulation plus dextran compared to low-dose heparin", Acta 
Neurochir.(Wien.), vol. 80,no. 3-4, pp. 83-89. 
 4.  Bynke, O., Hillman, J., & Lassvik, C. 1987, "Does peroperative external 
pneumatic leg muscle compression prevent post-operative venous 
thrombosis in neurosurgery?", Acta Neurochir.(Wien.), vol. 88,no. 1-2, 
pp. 46-48. 
 5.  Cerrato, D., Ariano, C., & Fiacchino, F. 1978, "Deep vein thrombosis 
and low-dose heparin prophylaxis in neurosurgical patients", 
J.Neurosurg., vol. 49,no. 3, pp. 378-381. 
 6.  Clagett, G. P. & Reisch, J. S. 1988, "Prevention of venous 
thromboembolism in general surgical patients. Results of meta-
analysis", Ann.Surg., vol. 208,no. 2, pp. 227-240. 
  26
 7.  Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. 1988, "Reduction in 
fatal pulmonary embolism and venous thrombosis by perioperative 
administration of subcutaneous heparin. Overview of results of 
randomized trials in general, orthopedic, and urologic surgery", 
N.Engl.J.Med., vol. 318,no. 18, pp. 1162-1173. 
 8.  Dalen, J. E. & Alpert, J. S. 1975, "Natural history of pulmonary 
embolism", Prog.Cardiovasc.Dis., vol. 17,no. 4, pp. 257-270. 
 9.  Department of Haematology, R. Royal North Shore Hospital 
Anticoagulation Guidelines 1997.  1-7-1998.  
Ref Type: Internet Communication 
 10.  di Ricco, G., Marini, C., Rindi, M., Ravelli, V., Lutzemberger, L., Tusini, 
G., & Giuntini, C. 1984, "Pulmonary embolism in neurosurgical patients: 
diagnosis and treatment", J.Neurosurg., vol. 60,no. 5, pp. 972-975. 
 11.  Dickinson, L. D., Miller, L. D., Patel, C. P., & Gupta, S. K. 1998, 
"Enoxaparin increases the incidence of postoperative intracranial 
hemorrhage when initiated preoperatively for deep venous thrombosis 
prophylaxis in patients with brain tumors", Neurosurgery, vol. 43,no. 5, 
pp. 1074-1081. 
 12.  Flinn, W. R., Sandager, G. P., Cerullo, L. J., Havey, R. J., & Yao, J. S. 
1989, "Duplex venous scanning for the prospective surveillance of 
perioperative venous thrombosis", Arch.Surg., vol. 124,no. 8, pp. 901-
905. 
 13.  Flinn, W. R., Sandager, G. P., Silva, M. B., Jr., Benjamin, M. E., Cerullo, 
L. J., & Taylor, M. 1996, "Prospective surveillance for perioperative 
venous thrombosis. Experience in 2643 patients [see comments]", 
Arch.Surg., vol. 131,no. 5, pp. 472-480. 
 14.  Frim, D. M., Barker, F. G., Poletti, C. E., & Hamilton, A. J. 1992, 
"Postoperative low-dose heparin decreases thromboembolic 
complications in neurosurgical patients", Neurosurgery, vol. 30,no. 6, 
pp. 830-832. 
 15.  Hamilton, M. G., Hull, R. D., & Pineo, G. F. 1994, "Venous 
thromboembolism in neurosurgery and neurology patients: a review", 
Neurosurgery, vol. 34,no. 2, pp. 280-296. 
 16.  Hauch, O., Khattar, S. C., & Jorgensen, L. N. 1991, "Cost-benefit 
analysis of prophylaxis against deep vein thrombosis in surgery", 
Semin.Thromb.Hemost., vol. 17 Suppl 3, pp. 280-283. 
 17.  Huber, O., Bounameaux, H., Borst, F., & Rohner, A. 1992, 
"Postoperative pulmonary embolism after hospital discharge. An 
underestimated risk", Arch.Surg., vol. 127,no. 3, pp. 310-313. 
  27
 18.  Hull, R. D., Feldstein, W., Pineo, G. F., & Raskob, G. E. 1995, "Cost 
effectiveness of diagnosis of deep vein thrombosis in symptomatic 
patients", Thromb.Haemost., vol. 74,no. 1, pp. 189-196. 
 19.  Hull, R. D., Hirsh, J., Carter, C. J., Jay, R. M., Ockelford, P. A., Buller, 
H. R., Turpie, A. G., Powers, P., Kinch, D., & Dodd, P. E. 1985, 
"Diagnostic efficacy of impedance plethysmography for clinically 
suspected deep-vein thrombosis. A randomized trial", Ann.Intern.Med., 
vol. 102,no. 1, pp. 21-28. 
 20.  Hull, R. D., Raskob, G. E., & Hirsh, J. 1986, "Prophylaxis of venous 
thromboembolism. An overview", Chest, vol. 89,no. 5 Suppl, pp. 374S-
383S. 
 21.  Kakkar, V. V. & Stringer, M. D. 1990, "Prophylaxis of venous 
thromboembolism", World J.Surg., vol. 14,no. 5, pp. 670-678. 
 22.  Lawrence, J. C., Xabregas, A., Gray, L., & Ham, J. M. 1977, "Seasonal 
variation in the incidence of deep vein thrombosis", Br.J.Surg., vol. 
64,no. 11, pp. 777-780. 
 23.  Loxley, W., Homel, R., Berger, D., & Snortum, J. 1992, "Drinkers and 
their driving: compliance with drinking-driving legislation in four 
Australian states", J.Stud.Alcohol, vol. 53,no. 5, pp. 420-426. 
 24.  McKenzie, P. J., Wishart, H. Y., Gray, I., & Smith, G. 1985, "Effects of 
anaesthetic technique on deep vein thrombosis. A comparison of 
subarachnoid and general anaesthesia", Br.J.Anaesth., vol. 57,no. 9, 
pp. 853-857. 
 25.  Modig, J., Hjelmstedt, A., Sahlstedt, B., & Maripuu, E. 1981, 
"Comparative influences of epidural and general anaesthesia on deep 
venous thrombosis and pulmonary embolism after total hip 
replacement", Acta Chir Scand., vol. 147,no. 2, pp. 125-130. 
 26.  Naso, F. 1974, "Pulmonary embolism in acute spinal cord injury", 
Arch.Phys.Med.Rehabil., vol. 55,no. 6, pp. 275-278. 
 27.  Nicolaides, A. N., Arcelus, J., Belcaro, G., Bergqvist, D., Borris, L. C., 
Buller, H. R., Caprini, J. A., Christopoulos, D., Clarke-Pearson, D., & 
Clement, D. 1992, "Prevention of venous thromboembolism. European 
Consensus Statement, 1-5 November 1991, developed at Oakley Court 
Hotel, Windsor, UK [editorial]", Int.Angiol., vol. 11,no. 3, pp. 151-159. 
 28.  Powers, S. K. & Edwards, M. S. 1982, "Prophylaxis of 
thromboembolism in the neurosurgical patient: a review", Neurosurgery, 
vol. 10,no. 4, pp. 509-513. 
 29.  Rooke, T. W. & Osmundson, P. J. 1986, "Heparin and the in-hospital 
management of deep venous thrombosis: cost considerations", Mayo 
Clin.Proc., vol. 61,no. 3, pp. 198-204. 
  28
 30.  Sabiston, D. C., Jr. 1979, "Pathophysiology, diagnosis, and 
management of pulmonary embolism", Am.J.Surg., vol. 138,no. 3, pp. 
384-391. 
 31.  Sandler, M. S., Velchik, M. G., & Alavi, A. 1988, "Ventilation 
abnormalities associated with pulmonary embolism", Clin.Nucl.Med., 
vol. 13,no. 6, pp. 450-458. 
 32.  Sigel, B., Ipsen, J., & Felix, W. R., Jr. 1974, "The epidemiology of lower 
extremity deep venous thrombosis in surgical patients", Ann.Surg., vol. 
179,no. 3, pp. 278-290. 
 33.  Swann, K. W. & Black, P. M. 1984, "Deep vein thrombosis and 
pulmonary emboli in neurosurgical patients: a review", J.Neurosurg., 
vol. 61,no. 6, pp. 1055-1062. 
 34.  Turpie, A. G., Gallus, A., Beattie, W. S., & Hirsh, J. 1977, "Prevention of 
venous thrombosis in patients with intracranial disease by intermittent 
pneumatic compression of the calf", Neurology, vol. 27,no. 5, pp. 435-
438. 
 35.  Turpie, A. G., Hirsh, J., Gent, M., Julian, D., & Johnson, J. 1989, 
"Prevention of deep vein thrombosis in potential neurosurgical patients. 
A randomized trial comparing graduated compression stockings alone 
or graduated compression stockings plus intermittent pneumatic 
compression with control", Arch.Intern.Med., vol. 149,no. 3, pp. 679-
681. 
 36.  Velmahos, G. C., Oh, Y., McCombs, J., & Oder, D. 2000, "An evidence-
based cost-effectiveness model on methods of prevention of 
posttraumatic venous thromboembolism.[In Process Citation]", 
J.Trauma, vol. 49,no. 6, pp. 1059-1064. 
 37.  Voth D, S. M. H. K. e. a. 1992, "Prevention of deep vein thrombosis in 
neurosurgical patients: a prospective double-blind comparison of two 
prophylactic regimen.", Neurosurg Rev, vol. 15,no. 4, pp. 289-294. 
 38.  Watson, N. 1974, "Anticoagulant therapy in the treatment of venous 
thrombosis and pulmonary embolism in acute spinal injury", Paraplegia, 
vol. 12,no. 3, pp. 197-201. 
 39.  White, R. H., McGahan, J. P., Daschbach, M. M., & Hartling, R. P. 
1989, "Diagnosis of deep-vein thrombosis using duplex ultrasound [see 
comments]", Ann.Intern.Med., vol. 111,no. 4, pp. 297-304. 
 
 20
CHAPTER 2 – METHODS 
 
2.1 - DATA VALIDATION 
 
The database tables of admissions, diagnoses, operations, complications and 
comments for admissions from May 1976 until September 1999 were examined for 
accuracy and completeness.  All fields were sorted by ascending data to find any 
suspiciously outlying values, which were checked against original documents, for 
example a length of stay of 530 days.  Individual admission dates were checked as 
being earlier than discharge dates.  Missing data was entered from the original 
documents.  138 known such errors were detected and repaired.  Cases with DVT 
or PE were checked against their comment fields to confirm their status, and 
investigated for a death coding.  Morbidity and Mortality meeting reports for the last 
ten years were reviewed for any further information.   An incidental audit of records 
of patients receiving thiopentone coma with another hospital department revealed 
perfect agreement.  At the end of this procedure there was no obviously missing 
data.  Less than 0.5% of patients within the inclusion criteria were not added to the 
database during the 23-year period because their medical record notes were not 
available.     
 
2.2  INCLUSION AND EXCLUSION CRITERIA 
2.2.1  Database criteria for DVT:   
The study is about DVT and PE which are documented and recognised on clinical 
grounds.  It includes new thromboses in soleal sinusoids, peroneal, femoral, iliac, 
popliteal, gastrocnemius, posterior tibial, IVC, pelvic or axillary veins, documented 
by venography or duplex scan (Doppler + ultrasound).  Thromboses in any of these 
locations was included, even though some sites are regarded as more serious than 
others, because of the nature of DVT evolution over the course of an admission and 
because of difficulty in recording locations and size of DVT in the early years of the 
database due to methodological limitations.  DVT on admission was excluded, even 
if this was a readmission with DVT after a previous neurosurgical admission, 
because not all DVTs arising after discharge would be admitted to the same hospital 
or under the care of a neurosurgeon, making it difficult to find these cases.  The 
study cannot include “silent” DVT, even though these may exist in patients with PE. 
2.2.2  Database criteria for PE:  
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High probability of PE documented on VQ scan; or intermediate probability of PE 
documented on VQ scan plus clinical symptoms such as chest pain, shortness of 
breath, respiratory alkalosis (hypoxia & hypocapnia). 
From the validated data set, initially cut-off points were chosen to include discharges 
for the 23-year period from 1/10/76 to 30/9/99 so as to include as many complete 
years as possible for analysis.   
 
2.3 PRELIMINARY EXPLORATION OF DVT AND PE DISTRIBUTION 
 
2.3.1  Incidence of DVT, PE and death over time 
Variables recorded in the database which may help to predict DVT and PE were 
systematically analysed to determine their relationship to the incidence of DVT and 
PE.  Variables available for the whole period of the database were age, sex 
admitting surgeon, admission and discharge dates, diagnosis, operation and 
complications.  First, using Microsoft Access queries and Microsoft Excel, 
descriptive statistics were prepared for incidence of DVT, PE and death in the entire 
database over time (Table 3.1 and Fig 3.1.1).  
Incidence was calculated as follows: 
  
Incidence of DVT, PE or death per discharge over time = 
          discharges with DVT, PE or death in a period (n) x 100 
     total discharges in that period (n) 
The observation of a fall in death rate over time prompted a breakdown of death rate 
according to diagnostic group to see if any particular group contributed more to this 
(Table 3.1.1). 
 
2.3.2  Statistical confirmation of trends 
To confirm the impressions gained from Fig. 3.1.1, patient discharges were divided 
into four groups spanning five years each.  The earliest discharges, from May 1976 
to December 31 1978, were not included so that groups could span equal periods 
and for ease of analysis.  The four groups including discharges dated from 1/1/1979 
to 31/12/1998 are collectively referred to in this treatise as “the population under 
study”.  
Analyses were run in Minitab for χ² test statistics to determine any significant 
differences between groups, and in SAS for Mantel-Haenszel χ² values to test for 
trend across the DVT and PE groups. 
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One-way analysis of variance using unstacked data in Minitab was used to compare 
group averages. 
Distribution of DVT, PE and death from all causes in the population under study 
were calculated and are displayed in Table 3.1.2. 
 
2.4  EXPLORATION OF POTENTIAL PREDICTORS OF DVT AND PE 
Means and proportions of age, sex, length of stay and operative status in the four 
five-year periods were computed (Table 3.2.1) with relevant test statistics to 
determine whether the distribution of these basic potential predictors changed over 
the period 1979 to 1998.  The distribution of DVT and PE according to potential 
predictors was then further explored as below.  Death was no longer included in the 
analysis because its relationship to DVT and PE in this database is not known. 
 
2.4.1.  Incidence of DVT and PE by age 
Age was chosen as a potential predictor of DVT and PE because it is known to 
affect many health outcomes.  Initially, incidences of DVT and PE were plotted from 
the entire database of discharges against their age (Fig 3.2.2) using a similar 
formula to that in Chapter 2.3.1.  For analysis in the five-year periods, age groups 
were set at 0-29, 30-44, 45-59, 60-74 and 75+ years.  Distribution of DVT and PE 
were calculated over each of the four five-year discharge periods, with χ2 measures 
to test for significant differences between age groups within each period and 
between periods across the age groups (Tables 3.2.2.1, 3.2.2.3).  χ2  test statistics 
were also obtained for the age groups across the period of the population under 
study, 1979-98 (Tables 3.2.2.2 and 3.2.2.4).  
 
2.4.2  Incidence of DVT and PE by sex 
Sex was chosen as a variable in this study because it can be a determinant in many 
health outcomes.  
DVT and PE rates with χ2   test statistics were calculated for each sex (Table 3.2.3).  
Rates were broken down into periods (Table 3.2.3.1).  
 
 
2.4.3  Incidence of DVT and PE by month 
Because we have noted clusters of DVT and PE in our regular Morbidity and 
Mortality meetings, and reports of fluctuations in the rate of PE with season in the 
literature (Lawrence, Xabregas, et. al. 1977), a graph was prepared (Fig. 3.2.4) to 
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show their seasonal distribution using a similar formula to that in Chap 2.3.1.  
Another analysis of DVT and PE was run by admission month in a similar way (Fig 
3.2.5), because the onset of DVT and PE in hospital may have a stronger 
relationship in time to admission date than discharge date because of the varying 
lengths of hospital stay. Predictive factors such as age and sex, analysed here by 
discharge date, remain relatively constant for a hospital stay. 
Because of the pattern seen in this graph, cases with DVT and PE grouped by 
admission month were analysed in Minitab to confirm any differences in incidence 
between the months (Chapter 3.2.4). 
 
2.4.4  Incidence of DVT and PE by length of hospital stay (LOS): 
 Length of stay is likely to be a predictor of DVT and PE because prolonged 
immobilisation in bed of susceptible patients with stasis of blood in the limbs will 
favour the formation of thromboembolism.  LOS was calculated as follows: 
 
                LOS = [ Discharge date] - [admission date] in days.   
 
A preliminary graph of DVT and PE incidence according to LOS and distribution of 
DVT and PE by LOS over the four five-year periods were prepared (Chapter 3.2.5) 
using a formula similar to that in Chap. 2.3.1. 
 
2.4.5  Incidence of DVT and PE by diagnosis  
Diagnostic groups were defined as in the database table of diagnoses, i.e, tumour 
(not spinal), vascular (not spinal), trauma (not spinal), spinal (including spinal 
tumours, vascular malformations and trauma).  Some diagnoses such as brain 
abscess, trigeminal neuralgia and peripheral nerve conditions do not fit into these 
categories and were placed in a group named “Other”.  Counts were obtained for 
the first four groups and the total using Access queries, and for “Other” by 
subtraction of the first four groups from the total.  Where cases were included in two 
or more groups, they were reviewed individually and classified into just one group, 
taking account of the operations performed and comments recorded in the 
Comments table.  For example, if a patient was admitted for management of a 
tumour, but suffered a subarachnoid haemorrhage during operation for the tumour 
with consequent prolonged hospital stay and increased morbidity, that patient would 
be classified in the vascular, not tumour group. 
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The distribution of diagnostic groups was examined in the four five-year groups, 
then distribution of DVT and PE by diagnostic group was calculated across the five-
year groups (Chapter 3.2.6). 
 
2.4.6  Incidence of DVT and PE by surgical group 
The literature reports wide variation in the incidence of DVT and PE in different 
surgical groups, with orthopaedic surgery tending to be highest.  Some spinal 
operations in the RNSH Neurosurgery database would be classified as orthopaedic, 
whereas the minor peripheral nerve operations would be considered to have low 
incidence of DVT and PE.  As was done with diagnostic groups, distribution of all 
discharges in the four five-year groups by type of surgery was calculated (Chapter 
3.2.7).  This grouping was created because patients with a particular diagnosis may 
have several treatment options.  For example, a patient with a cerebral aneurysm 
could have endovascular treatment in the radiology department, no surgery, or a 
surgical repair. Thus the diagnostic and surgical groups are not identical.  The 
literature suggests that surgery is a contributor to thrombogenesis, therefore 
patients without surgery are at less risk of DVT or PE. Surgery groups were defined 
as in the database table of operations, i.e. operations for brain tumour (not spinal), 
vascular conditions (not spinal), trauma (not spinal), spinal conditions (including 
spinal tumours, spinal vascular conditions and spinal trauma). The proportions of 
spinal tumours and vascular conditions in the spinal group would be small.  Any 
other operations, such as peripheral nerve operations, were classified as “other”.  
Thirty cases were coded for two or more groups. They were reviewed individually, 
taking account of all the information available.  For example, where a patient 
underwent excision of a tumour and of a haematoma from that tumour, the case 
was classified as “tumour” because the admission was for management of the 
tumour.  It was assumed that the effects of haemorrhage did not over-ride the 
tumour classification.  If a patient was coded for an “Other” classification and 
another classification, the “Other” classification was over-ridden.  “The “No surgery” 
group may include patients who had endovascular procedures in the radiology 
department but did not go to the operating room during their admission.  Distribution 
of DVT and PE in the surgical groups across the five-year periods was calculated 
and is shown in Tables 3.2.7.2 and 3.2.7.3. 
 
2.4.7  Incidence of DVT and PE by admitting surgeon 
Another variable recorded in the database and an obvious one to be considered in 
this analysis is the surgeon responsible for the patient’s care while in hospital.  This 
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surgeon is also most likely to be the operating surgeon if the patient goes to theatre, 
if only in a supervisory capacity.  Surgeons 1 and 2 were well established in their 
practices at the beginning of the database in 1976, and retired during the period of 
the database.  Surgeons 3, 4, 5, 6 and 7 commenced practice during the database 
period and are still in practice. Where a patient was transferred from the care of one 
surgeon to another, the surgeon who performed any operation was allocated to that 
discharge.  Some overlap between surgeon, diagnostic group and surgical group 
exists, but this is not easy to measure.   
Graphs were made showing the distribution of DVT and PE by year for the individual 
surgeons (Figs 3.2.8.1. and 3.2.8.2). Distribution of diagnostic group according to 
surgeon was calculated for all discharges in the database 1979 to 1998, then DVT 
and PE by surgeon for the same period, in the same manner as for incidence of 
DVT and PE by diagnosis.  Incidences were calculated as in Chap. 2.3.1. 
 
2.4.8 SUMMARY   
χ2 values for the univariate analyses of potential predictors of DVT and PE as 
described in the preceding Chapter 2.4 were summarised (Table 3.3.1).  As the 
univariate analyses show that several variables have a marked association with 
DVT and PE rates, a multivariate logistic regression analysis was carried out to 
disentangle their effects.   
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2.5 FURTHER EXPLORATION OF PREDICTORS OF DVT AND PE USING 
MULTIVARIATE LOGISTIC REGRESSION 
 
2.5.1  Creation of Dataset for Logistic Regression 
Five fixed-width text tables were created via Access queries from the Neurosurgery 
database.  They contained variables as follows: 
a) Neuro no. (the unique identifier), age, sex, vmo (surgeon), discharge date and 
LOS for each admission;  
b) Neuro no. and DVT identifier for each admission with DVT; 
c) Neuro no. and PE identifier for each admission with PE; 
d) Neuro no. and diagnosis codes for each admission; 
e) Neuro no. and operation codes for each admission. 
These tables were loaded into Statistical Analysis System (SAS) v. 6.12, and 
merged by the identifier Neuro no. into one dataset.  
Age, discharge date and LOS were kept as continuous variables.  DVT, PE, sex, 
vmo, diagnostic group and surgical group were used as categorical variables. 
In order to correct the non-linearity for age seen in Fig. 3.2.2, a new categorical 
variable, “agegp”, was created, taking the value 1 where age ≥ 80 years, and 0 
otherwise. 
To correct for the non-linearity for LOS seen in Fig. 3.2.5, a new categorical 
variable, “losgp”, was created, taking the value 1 for LOS is 80-89 days, 2 for LOS ≥ 
90 days and 0 otherwise. 
To correct for the non-linearity for discharge date seen in Fig. 3.1.1, three new 
dummy variables for the four time periods were created: Period2 for discharge dates 
between 1/1/84 and 31/12/88, Period3 for discharge dates between 1/1/89 and 
31/12/93 and Period4 for discharge dates between 1/1/94 and 31/12/98. 
    
2.5.2 Logistic Regression Analysis 
Logistic regression models were run using the forward method of stepwise addition 
of variables to the model, retaining only variables which provided a significant 
contribution to the model. Sexgp was not included in the model as univariate 
analysis indicated an insignificant influence on the incidence of DVT or PE. The 
forward stepwise method was chosen because of expected collinearities between 
vmo, diagnostic groups and surgical groups.  A test for significance for variables 
added was obtained by subtracting the χ2 value and the degrees of freedom of the 
preceding model from those for the model with newly added variables. Significance 
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levels were kept strictly to less than 0.01 or 1% for inclusion of variables in the 
model.  An odds ratio with 95% confidence intervals is provided for each variable in 
the SAS printout for the regression analysis.  The model of best fit was chosen on 
the basis of the highest χ2 value, and for the addition of single (not dummy) 
variables, to a P value of <0.01. 
 
The following models were run for DVT: 
a) DVT as outcome variable with los, losgp, periods, age, agegp (Table 
3.4.1.1). 
Vmo’s, diagnostic and operation groups were then placed in the model separately  
(Table 3.4.1.2). 
In order to determine whether diagnoses and operations predicted DVT more 
accurately individually rather than as groups, they were ranked in order of incidence 
of DVT (Tables 3.4.2, 3.4.3). All diagnoses and operations are included in these 
tables for interest and comparisons, but only those recorded over the full twenty 
years will be evaluated in the following analyses. Further models were then run as 
follows:  
 
b )  DVT with its base model and the five individual diagnoses with the highest         
      incidences of DVT taken from Table 3.4.2, where only those diagnoses with      
      five or more cases were considered (Table 3.4.2.1). 
c ) DVT with its base model and individual operations associated with the highest       
     incidences of DVT taken from Table 3.4.3, where only those operation groups    
     with five or more cases were considered (Table 3.4.3.1). 
 
Logistic regression analysis for PE was done the same way as for DVT.  Diagnoses 
and operations from the database were ranked for incidence of PE (Tables 3.4.5 
and 3.4.6).  Models were run as follows: 
 
d) PE as outcome variable with vmo, diagnosis and operation groups as in a). 
(Tables 3.4.4.1 and 3.4.4.2). 
 
e) PE with its base model and the five individual diagnoses associated with the 
highest incidences of PE taken from Table 3.4.5.  Only those diagnoses with five or 
more cases of PE were used in the analysis (Table 3.4.5.1). 
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f) PE with its base model and individual operations associated with the highest 
incidences of PE taken from Table 3.4.6.  Only those operations with five or more 
cases of PE were used (Table 3.4.6.1). 
 
The logistic regression analysis, with effects of surgeon, diagnosis and operation on 
the incidence of DVT and PE adjusted for length of stay, period and age were 
summarised (Tables 3.4.7.1 and 3.4.7.2). 
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CHAPTER 3 - RESULTS 
 
3.1  PRELIMINARY EXPLORATION OF DVT, PE and DEATH 
DISTRIBUTION 
 
The broad analysis of the incidence of DVT, PE and death in the entire database of 
discharges from 1976 to 1998 is shown in Table 3.1. 
 
Table 3.1 - Descriptive Statistics for DVT, PE and Death:   
 1976 – 1999 
 
 n % of total discharges % female 
All discharges 21733 100 41.8 
DVT 384 1.77 43.0 
PE 161 0.74 39.8 
Death: all causes 1368 6.30 42.0 
Death with DVT 17 4.4% of discharges with DVT 23.5 
Death with PE 30 18.6% of discharges with PE 40.0 
 
 
The incidence of DVT at 1.77% is seen to be more than double that of PE at 0.74%.  
The ratio of male to female cases is surprisingly constant at about 60:40 for all 
parameters except for death with DVT, where it is higher at 76:24. 
The higher incidence of death in-patients with PE is noted. The rate of death with 
DVT is only about one quarter that of death with PE. 
 
67 of the patients with DVT also were found to have a PE.   
317 patients had DVT without PE. 
94 patients had PE without DVT.  
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3.1.1  Incidence of DVT, PE and Death over Time: Discharges 1976 - 1999 
 
In Fig. 3.1.1, the most impressive finding is that the rate of DVT is seen to remain 
constant until 1983, when it doubles to a rate of about 1%.  Between 1991 and 1992 
it begins a marked rise, which is maintained beyond the end of 1998 to more than 
ten times its rate in 1976. The rate of PE, however, while it doubles at about 1990, 
does not rise beyond this time.  While the rise in incidence of DVT is of concern, it is 
not accompanied by an increase in deaths; rather, the rise in DVT rate is concurrent 
with a fall in death rate.  
Fig. 3.1.1: Distribution of DVT, PE & death over time - 
entire database 1976 - 99
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Table 3.1.1  Approximate* death rates by diagnostic group 1979 -98 
 
Discharge year:        1979-83 1984-88 1989-93 1994-98 
Diagnosis Death (n) 
All 
discharges 
(n) 
Death 
rate (%) 
Death 
(n) 
All 
discharges 
(n) 
Death 
rate (%)
Death 
(n) 
All 
discharges 
(n) 
Death 
rate (%)
Death 
(n) 
All dis-
charges 
(n) 
Death 
rate 
(%) 
tumour 48 702 6.8 33 849 3.9 19 879 2.2 19 967 1.96 
vascular 100 661 15.1 150 644 23.3 131 911 14.4 144 1358 10.60 
trauma 150 1524 9.8 163 1853 8.8 129 1401 9.2 127 1057 12.02 
spinal 21 1068 2.0 20 1061 1.9 24 1165 2.1 23 1013 2.27 
Other** N.K. N.K. N.K. N.K. N.K. N.K. N.K. N.K. N.K. N.K. N.K. N.K. 
total 306 4499 6.8 344 4969 6.9 286 4796 6.0 255 4831 5.28 
 
* Note 1: Totals for columns are greater than the values in the “total” row because some patients have multiple diagnosis codes in the 
database; table is for comparison of general trends only. 
 
** Note 2: N.K.: not known.  It is not possible to calculate meaningful values for death by “other” diagnosis because of time constraints and 
methodological limitations with Access queries. 
 
 32 
3.1.2  Statistical confirmation of trends 
 
Distribution of DVT, PE and death from all causes in the population under study is 
shown in Table 3.1.2. 
 
Table 3.1.2   - Distribution of DVT, PE and death in five-year periods: 1979 - 98 
Year of 
discharge 1979-83 1984-88 1989-93 1994-98
1979-98 
(all) 
χ2 
3DF (P) 
χ2MH 
1DF (P) 
DVT (n)  29 (0.64%)
61 
(1.22%)
67 
(1.40%)
174 
(3.60%)
331 
(1.73%)
141.08, 
P<0.001 
114.20, 
P<0.001 
PE (n) 27 (0.60%)
15 
(0.30%)
42 
(0.88%)
57 
(1.18%)
141 
(0.74%)
28.22, 
P<0.001 
17.94, 
P<0.001 
Death (all 
causes) (n) 
306 
(6.8%)
345 
(6.9%)
286 
(6.0%) 
255 
(5.3%)
1192 
(6.2%)
14.78 
P=0.002 
12.56 
P<0.01 
Death and DVT 2 (0.04%)
4 
(0.08%)
2 
 (0.04%) 
6 
(0.12%)
14 
(0.07%)
2.91 
P=0.41 
1.29 
P=0.26 
Death and PE 8 (0.18%)
4 
(0.08%)
8 
(0.17%)
7 
(0.14%)
27 
(0.14%)
1.96 
P=0.58 
0.00 
P=0.99 
 
 
χ2 statistics show the rates of DVT in the four groups to be significantly different 
from each other, and the Mantel-Haenszel χ2 test statistic of 114.20 shows a 
significantly increasing trend from 0.64% to 3.60% of discharges over the twenty-
year period. 
Similar results are obtained with the rates of PE, with the Mantel-Haenszel χ2 of 
17.94 showing a significantly increasing trend in rates of PE from 0.60% to 1.18% 
over the twenty-year period. 
There is a significant trend seen in the declining death rate over the twenty-year 
period with the Mantel-Haenszel χ2 of 12.56, P<0.01, confirming the impression 
from Table 3.1.1.   
There is no significant difference for rates of DVT with death between the four 
periods, or for rates of PE with death.  There is, therefore, no evidence of a trend.  
Understandably, the rates with death are higher for PE than for DVT, as PE is more 
likely to be a fatal condition than is DVT.       
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3.2 EXPLORATION OF POTENTIAL PREDICTORS OF DVT AND PE 
 
Analysis of some basic characteristics of the population under study is shown in 
Table 3.2.1. 
 
Table 3.2.1 -  Distribution of some potential predictors in five-year periods: 
1979-98 
 
Year of 
discharge: 1979-83 
1984-
88 1989-93 1994-98 
1979-
98 (all) 
F 
3,19098 
DF 
χ² 
3DF 
 
χ²MH 
1DF 
(test for 
trend) 
 
Dis- 
charges (n) 4500 4975 4796 4831 19102    
Mean age 
(years) 
42.0;   
range 
0:93 
42.9; 
range 
0:95 
47.1; 
range 
0:99 
50.4; 
range 
0:95 
45.6; 
range 
0:99 
168.0 
P<0.001   
Sex = M 60.8% 58.2% 58.6% 54.8% 58.1%  35.4 P<0.001 
29.4 
P<0.01 
Mean LOS 
(days) 
19.4 
range 
0:367 
15.6 
range 
0:594 
14.5 
range 
0:508 
13.1 
range 
0:255 
15.6 
range 
0:594 
76.6 
P<0.001   
Operated 
(Yes) 
 
% operated 
2619  
 
 
58.2% 
2824  
 
 
56.8% 
2974  
 
 
62.0% 
2962  
 
 
61.3% 
11379  
 
 
59.6% 
 37.7 P<0.001 
21.3 
P<0.001 
 
 
The groups are of roughly equal size.  Mean age is seen to increase significantly 
over the whole period studied from 42.0 to 50.4 years.  (F with 3,19098 degrees of 
freedom = 168.0, P<0.001).  The proportion of males to females varied significantly 
over the period (χ² =35.43, 3df, P<0.001) with a decline from 60.8% in the early 
years to 54.8% in the later years.  The Mantel-Haenszel chi-squared test statistic for 
trend here is 29.4 with 1 df, P<0.01.  Mean LOS declines over the twenty-year 
period from 19.4 days to 13.1 days (F with 3, 19098 degrees of freedom =76.6 
P<0.001).  The number of patients treated with surgery increases significantly from 
58.2% in 1979-83 to 61.3% in 1994-98 (χ2MH test for trend with 1DF =21.3, 
P=0.001). 
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3.2.2 Incidence of DVT and PE by Age 
 
Distribution of DVT and PE by age for discharges in the entire database is shown in 
Fig. 3.2.2.  
 
 
Figure 3.2.2 shows a general increase in incidence of DVT from 0.6% for 10-19 
years to 2.8% for 70-79 years and then a decrease to about 2% for the oldest age 
group.  The rate for PE follows the same pattern as seen for DVT. 
When analysed by five-year periods (Table 3.2.2.1), there was a significant 
difference in the incidence of DVT between time periods for each age group except 
for the 0-29 year olds.  There were also significant differences in DVT incidences 
between age groups over the 1984-88 and the 1994-98 periods (columns in Table 
3.2.2.1) and over the whole period 1979-98 (Table 3.2.2.2).  
Fig. 3.2.2: Distribution of DVT and PE by age - 
entire database 1976 - 99
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Table 3.2.2.1 - Distribution of DVT by age in five-year periods: 1979-98 
 
Discharge year:     1979-83 1984-88 1989-93 1994-98  
Age 
group 
With 
DVT (n) 
All dis-
charges 
% with 
DVT 
With 
DVT (n)
All dis-
charges
% with 
DVT 
With 
DVT (n)
All dis-
charges 
% with 
DVT 
With 
DVT (n)
All dis-
charges
% with 
DVT 
X2 
3df 
0-29 6 1478 0.41 10 1639 0.61 14 1179 1.12 10 885 1.13 7.28, P<0.10 
30-44 2 855 0.23 8 918 0.87 15 952 1.58 36 995 3.62 38.01, P<0.001
45-59 9 1086 0.83 14 1038 1.35 11 1039 1.06 45 1124 4 40.12, P<0.001
60-74 12 872 1.4 25 1028 3.43 23 1169 1.97 63 1305 4.83 29.57, P<0.001
75+ 0 209 0 4 351 1.14 3 457 0.66 21 522 4.02 22.43, P<0.001
X2 4df 12.79, P<0.025 18.58, P<0.001 6.12, P<0.025 21.89, P<0.001  
All ages 29 4500 0.64 61 4975 1.22 66 4796 1.38 175 4831 3.62 141.08, P<0.001
 
 

   
Table 3.2.2.2 – Distribution of DVT by age - totals- all years 1979-98 
 
Discharge 
year: 
All years: 1979 – 98 
Age group  DVT (n) All discharges (n) % with DVT X2 4df 
0-29 40 5181 0.77  
30-44 61 3720 1.64  
45-59 79 4287 1.84  
60-74 123 4374 2.81  
75+ 28 1539 1.82 58.57, P<0.001 
All ages 331 19102 1.73  
 
 
Table 3.2.2.4 – Distribution of PE by age- totals – all years 1979-98 
 
Discharge 
year: All years: 1979 – 98 
Age group PE (n) All discharges (n) % with PE X2 4df 
0-29 14 5181 0.27  
30-44 18 3720 0.48  
45-59 44 4287 1.03  
60-74 47 4374 1.07  
75+ 18 1540 1.17 34.28, P<0.001 
All ages 141 19102 0.74  
 
However, when analysed the same way (Tables 3.2.2.3 and 3.2.2.4), no significant 
difference is seen in the incidence of PE between the five-year groups.  The only 
period for which age groups show significant differences are 1979-83, with a chi-
squared statistic of 24.48 with 4 degrees of freedom.  Over all time, the age groups 
differ significantly from each other, with X2 = 34.28, P<0.001.  

   
Table 3.2.2.3 – Distribution of PE by age in five-year periods: 1979-98 
 
Discharge year:      1979–83 1984–88 1989-93 1994-98  
Age 
group 
With 
PE 
(n) 
Total 
(n) 
% 
with 
PE 
With 
PE 
(n) 
Total 
(n) 
% 
with 
PE 
With 
PE 
(n) 
Total 
(n) 
% 
with 
PE 
With 
PE 
(n) 
Total 
(n) 
% 
with 
PE 
X2 3 df 
0-29 2 1478 0.14 3 1640 0.18 4 1179 0.34 5 885 0.56 4.51*, P<0.250 
30-44 1 855 0.12 1 918 0.11 9 952 0.95 7 995 0.70 10.28*, P<0.025 
45-59 9 1086 0.83 6 1038 0.58 14 1039 1.35 15 1124 1.33 4.58, P<0.250 
60-74 14 872 1.61 4 1028 0.39 10 1169 0.86 19 1305 1.46 9.17, P<0.050 
75+ 1 209 0.48 1 351 0.28 5 457 1.09 11 522 2.11 7.23*, P<0.50 
X2 4df 24.48*, P<0.001 4.81*, P<0.500 6.88*, P<0.250 9.74, P<0.050  
All 
ages 27 4500 0.60 15 4975 0.30 42 4796 0.88 57 4831 1.18 
28.22, 
P<0.001 
 
 
* χ2   values may be of doubtful validity due to small frequencies in these cells  
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 3.2.3 – Incidence of DVT and PE by sex 
 
Table 3.2.3 - Distribution of DVT and PE by sex - 1979 – 98 
  
 All Discharges 
With DVT 
(n) 
% with 
DVT With PE (n) 
% with 
PE 
Male 11092 193 1.74 88 0.79 
Female 8010 138 1.72 53 0.66 
All 19102 331 1.73 141 0.74 
χ² with 3 
DF  
0.18, 
P<0.75  
1.01 
P<0.90  
 
There was no significant difference in the incidence of either DVT or PE in males 
and females in the population under study over all time.  
 
Table 3.2.3.1 –DVT and PE by sex in five-year periods 
 
Sex 1979-83 1984-88 1989-93 1994-98 
Males with DVT 
(n) 
17 (59%) 31 (51%) 40 (61%) 57 (59%) 
All with DVT (n) 29 61 66 175 
Males with PE (n) 17(63%) 9 (64%) 27 (64%) 35 (61%) 
All with PE (n) 27 15 42 57 
 
There does not appear to be any difference between the sexes in DVT or PE rates 
over time. 
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3.2.4 – Incidence of DVT and PE by month 
 
The distribution for DVT and PE according to month of discharge over the entire 
period covered by the database is shown in Fig. 3.2.4.1.  The plot for PE does 
appear to mirror that for DVT, with dips in March, and again in October and 
November.   
 
 
Fig.  3.2.4.2: Distribution of DVT and PE by admission month -  1976-99 
 
Fig. 3.2.4.1  Distribution of DVT and PE by discharge month - 
entire database 1976-99
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When DVT and PE are plotted against admission date, dips are seen again in 
Autumn and in Spring.  Results of χ2 analysis can be seen in Table 3.2.4. 
 
Table 3.2.4 – Incidence of DVT and PE by admission month: 1979-98 
Month of 
admission 
All 
admissions
With 
DVT (n) 
% 
with 
DVT 
With PE 
(n) 
% with 
PE 
January 1547 24 1.55 11 0.71 
February 1611 28 1.74 16 0.99 
March 1683 24 1.43 14 0.83 
April 1640 28 1.71 10 0.61 
May 1657 28 1.69 13 0.78 
June 1557 33 2.12 11 0.71 
July 1576 28 1.78 13 0.82 
August 1681 32 1.90 11 0.65 
September 1489 20 1.34 6 0.40 
October 1599 25 1.56 5 0.31 
November 1597 38 2.38 16 1.00 
December 1465 23 1.57 15 1.02 
All months 19102 331 1.73 141 0.74 
χ2 11 df  8.67 (P= 0.65)  
11.79 
(P=0.38)  
Mantel-
Haenszel χ2  
0.56 
(P=0.45)  
0.10 
(P=0.75)  
 
 
χ2 values of 8.67 for DVT (P<0.5) and 11.79 (P> 0.5) show no significant difference 
between the months, and of course there is no trend apparent.  Thus no effect of 
season can be observed on the incidence of DVT or PE. 
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3.2.5  Incidence of DVT and PE according to Length of Hospital Stay 
(LOS) 
 
The preliminary distribution of DVT and PE (Fig. 3.2.5) is shown below. 
 
This figure shows the expected increase of DVT incidence from almost zero at 0-19 
days’ stay to a maximum rate of 14% in patients staying two to three months, then a 
decline to about 3% for patients staying longer.  There appear to be two peaks for 
incidence of PE, at 30-39 days, which does not closely follow the pattern for DVT, 
and at 70-79 days, which does mimic the DVT pattern. 
Fig. 3.2.5. Distribution of DVT and PE by length of stay- 
1976 - 1999
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When the data are examined in the five-year periods (Table 3.2.5.1), significant 
differences are observed in the incidence of DVT between all lengths of stay over 
time.  These differences are most marked for the 20-39 day LOS group. Also, 
significant differences are observed in incidences of DVT between the LOS groups 
for individual periods of time and for the whole period (Table 3.2.5.2).  
 
Table 3.2.5.1 - Distribution of DVT by length of stay in five-year periods: 
1979-98 
 
Discharge year:   1979-83 1984-88 1989-93 1994-98 
LOS 
(days) 
DVT 
(n) 
Total 
(n) 
% 
with 
DVT 
DVT 
(n) 
Total 
(n) 
% 
with 
DVT 
DVT 
(n) 
Total 
(n) 
% 
with 
DVT 
DVT 
(n) 
Total 
(n) 
% with 
DVT 
X2 3df 
0-19 5 2981 0.2 4 3754 0.1 9 3771 0.2 36 3880 0.9 
43.7, 
P<0.001
20-39 8 996 0.8 29 843 3.4 24 752 3.2 86 698 12.3 
137.1, 
P<0.001
40-59 6 271 2.2 14 216 6.5 12 132 9.1 32 156 20.5 
45.01, 
P<0.001
60-79 6 72 8.3 9 69 13.0 9 69 13.0 17 54 31.5 
13.97 
P<0.001
80+ 4 180 2.2 5 88 5.6 12 72 16.7 4 43 9.3 
18.56* 
P<0.001
All 29 4500 0.6 61 4970 1.2 66 4796 1.4 175 4831 3.6  
X2 
4df: 
94.88* 215.02** 305.33** 82.94* 
 P<0.001 P<0.001 P<0.001 P<0.001 
       
* 2 or more cells contain expected values <5.0         
**χ2 statistic probably invalid- 1 cell or more with expected counts < 1.0 
 
Note:  χ2 values in this table are high because of large numbers in the analysis.  
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As expected from a review of Fig. 3.2.5.2, the length of stay groups differ 
significantly in incidence of DVT when combined over all time with χ2 = 839.84 with 
4 df, and P<0.001.   
 
Table 3.2.5.2 – Distribution of DVT by length of stay- totals for all years 
1979-98 
 
Discharge year: Total - 1979-98 
LOS (days) DVT (n)
All discharges 
(n) 
% with DVT X2 4df 
0-19 54 14386 0.4  
20-39 147 3289 4.5  
40-59 64 775 8.3  
60-79 41 264 15.5  
80+ 25 388 6.4 839.84, P<0.001
All 331 19102 1.7  
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Tables 3.2.5.3 and 3.2.5.4 show the distribution of PE according to LOS in the four 
five-year groups and over the period of the groups combined.  
 
Table 3.2.5.3 – Distribution of PE by length of stay in five-year periods: 
1979-98 
 
Discharge year:1979-83 1984-88 1989-93 1994-98  
LOS 
(days) 
PE 
(n) 
Total 
(n) 
% 
with 
PE 
PE 
(n) 
Total 
(n) 
% 
with 
PE 
PE 
(n)
Total 
(n) 
% 
with 
PE 
PE 
(n) 
Total 
(n) 
% with 
PE 
X2 3df 
0-19 6 2981 0.2 2 3754 0.1 5 3771 0.1 20 3880 0.5 20.61, 
P<0.001
20-39 8 996 0.8 7 843 0.8 16 752 2.1 23 698 3.3 20.69, 
P<0.001
40-59 5 271 1.9 1 216 0.5 5 132 3.8 5 156 3.2 5.75*, P<0.25
60-79 6 72 8.3 2 69 2.9 7 69 10.1 8 54 14.8 5.65*, P<0.25
80+ 2 180 1.1 3 93 3.2 9 72 12.5 1 43 2.3 18.50*, 
P<0.001 
All 27 4500 0.6 15 4975 0.3 42 4796 0.9 57 4831 1.5 
X24df: 88.67**, P<0.001 57.67, P<0.001 230.84, P<0.001 133.55**, P<0.001  
*   some cells of χ2 test have expected values < 5.0 
** some cells of χ2 test have expected values <1.0; test is probably invalid 
 
There are significant differences in incidence of PE between the five-year groups for 
LOS of 0-19 days, 20-39 days, and 80+ days.  There are also highly significant 
differences between the LOS groups within each five-year period.  However, doubt 
is cast on the validity of analysis because of small PE numbers in some cells.  
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As expected from a review of Chart 3.2.5.4, when combined over 1979-98, the LOS 
groups differ significantly in PE incidence with χ2 =387.00 with 4 df and P<0.001. 
 
Table 3.2.5.4 – Distribution of PE by length of stay in five-year periods: 
totals all years 1979-98 
 
Discharge 
year: 
Total  - 1979-98 
Length of 
stay (days) 
PE (n) 
All discharges 
(n) 
% with 
PE 
X2 4df 
0-19 33 14386 0.2  
20-39 54 3289 1.6  
40-59 16 775 2.1  
60-79 23 264 8.7  
80+ 15 388 3.9 387.00, P<0.001 
All 141 19102 0.7  
 
  
3.2.6  Incidence of DVT and PE according to Diagnosis 
.  Diagnostic group data are shown in Table 3.2.6.1. 
 
Table 3.2.6.1.  Distribution of diagnostic groups in all discharges 
 in five-year periods: 1979-1998 
 
Diagnostic 
group 
1979-83 1984-88 1989-93 1994-98 Total 
Tumour 702 849 879 967 3397
Vascular 661 644 911 1358 3574
Trauma 1524 1853 1401 1057 6103
Spinal 1068 1061 1165 1013 4304
Other 544 562 440 436 1798
Total 4499 4969 4796 4831 19175
 
χ² with 12 DF for all groups is 644.27, P<0.001.  The total number of admissions 
shown here is slightly higher than the actual because of some patients being 
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recorded in the database for more than one diagnosis.  There is an increasing 
proportion of tumour and vascular cases over time, a declining proportion of trauma 
cases over time while spinal cases remain relatively constant. 
Examination of the distribution of DVT in the five-year periods (Table 3.2.6.2) shows 
that DVT incidence is higher in all diagnostic groups in 1994-98 than it was in 1979-
83.  Significant differences occur within the vascular (1.1 to 5.5%), trauma (0.4 to 
3.3%), tumour (0.7 to 3.5%) and spinal (0.7 to 2.7%) groups over the twenty year 
period.   
The diagnostic groups also display significantly different DVT incidence within the 
1984-88, 1989-93 and 1994-98 groups, but not in the earliest five-year period.   
 
Table 3.2.6.3 shows the data in five-year periods for PE incidence.  Five χ2 test 
statistics indicate highly significant differences in PE incidence – between diagnostic 
groups within 1984-88 and 1989-93 and for the combined years, and between year 
groups within the spinal and trauma diagnostic groups.   
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Table 3.2.6.2 – Distribution of DVT by diagnostic group in five-year periods: 1979-98 
 
Year of discharge:       1979-83 1984-88 1989-93 1994-98 All years 1979-98 
Diagnosis DVT 
(n) 
All dis-
charges 
% 
with 
DVT 
DVT 
(n) 
All dis-
charges
% 
with 
DVT
DVT 
(n) 
All dis-
charges
% 
with 
DVT
DVT 
(n) 
All dis-
charges
% 
with 
DVT
DVT 
(n) 
All dis-
charges
% 
with 
DVT 
X2 for 
diagnostic 
group- all 
years- 3df 
Tumour 5 702 0.7 19 849 2.2 16 879 1.8 34 967 3.5 74 3397 2.2 15.74, P<0.010
Vascular 7 661 1.1 10 644 1.6 24 911 2.6 75 1358 5.5 116 3574 3.3 39.45, P<0.001
Trauma 6 1524 0.4 13 1853 0.7 12 1401 0.9 35 1057 3.3 66 5835 1.1 56.34, P<0.001
Spinal 7 1068 0.7 18 1061 1.7 14 1165 1.2 27 1013 2.7 66 4307 1.5 15.09, P<0.010
Other 4 545 0.7 2 568 0.4 0 440 0.0 7 436 1.6 13 1989 0.6 9.83*, P<0.025
X2 4df 3.39*, P<0.500 17.18, P<0.010 21.09, P<0.001 21.7, P<0.001 78.05, P<0.001  
All 29 4500 0.6 62 4975 1.3 66 4796 1.4 178 4831 3.7 335 19102 1.8  
 
*4 cells of χ2 analysis contain cells where expected values are <5.0 
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Table 3.2.6.3 –Distribution of PE by diagnostic group in five-year groups: 1979-98 
 
Year of discharge:    1979-83 1984-88 1989-93 1994-98 All years 1979-98 
Diagnosis 
PE 
(n) 
All dis-
charges 
% 
with 
PE 
PE 
(n) 
All dis-
charges
% 
with 
PE 
PE 
(n)
All dis-
charges
% 
with 
PE 
PE 
(n)
All dis-
charges 
% 
with 
PE 
PE 
(n)
All dis-
charges
% with 
PE 
X2 with 3df for 
diagnostic 
group all years 
Tumour 7 702 1.0 5 849 0.60 6 879 0.7 14 967 1.5 32 3397 0.9 4.44, P<0.250 
Vascular 9 661 1.4 5 644 0.8 14 911 1.5 22 1358 1.6 50 3574 1.4 2.42, P<0.500 
Trauma 8 1524 0.5 0 1853 0.0 2 1401 0.1 7 1057 0.7 17 5835 0.3 14.35, P<0.010
Spinal 2 1068 0.2 5 1061 0.5 19 1165 1.6 11 1013 1.1 37 4307 0.9 16.29, P<0.001
Other 1 545 0.2 0 568 0.0 1 440 0.2 3 436 0.7 5 1989 0.3 4.86, P<0.250 
X2 4 df 13.07*, P<0.025 15.50*, P<0.010 23.42*, P<0.001 6.26, P>0.250 46.42, P<0.001  
All 27 4500 0.60 15 4975 0.30 42 4796 0.88 57 4831 1.18 141 19102 0.74  
 
* some cells of χ2 test have expected values <5.0 
 49
3.2.7 Incidence of DVT and PE according to surgical group 
As was done with diagnostic groups, distribution of all discharges in the four five-
year groups by type of surgery was calculated and is shown in Table 3.2.7.1.  
 
Table 3.2.7.1 - Distribution of surgical groups in five-year periods: 
1979-98 
  
Type of surgery 1979 - 83 1984 - 88 1989 - 93 1984 - 98 All years 
Tumour 557 665 719 674 2615 
Vascular 353 352 454 615 1774 
Trauma 452 549 451 349 1801 
Spinal 633 670 775 653 2731 
Other 632 593 579 677 2481 
Total with 
surgery 
2627 2829 2978 2968 11402 
No surgery 1873 2146 1818 1863 7700 
 
χ² with 12 DF for all groups: 173.15, P<0.001, indicating that there are differing time 
patterns over the surgical groups.  The total for all years is only 11402 because 
7700 cases did not undergo surgery.  The vascular surgery group is the only group 
with a sustained increase in frequency over the twenty-year period.  
 
Table 3.2.7.2 shows the distribution of DVT in the five-year periods by type of 
surgery. Significant differences are seen over time within all surgical groups. 
Significant differences are seen between the types of surgery within the latest three 
five-year periods, but not for 1979-83. 
 
Table 3.2.7.3 shows the distribution of PE in the five-year periods by type of surgery.  
Significant differences are seen over time only within the Spinal group.  Significant 
differences are seen between the types of surgery within each five-year period, but 
doubt is cast on the validity of some analyses here because of small numbers of PE 
in many cells of the table.   
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Table 3.2.7.2 – Distribution of DVT by surgical group in five-year periods: 1979-98 
 
Year of discharge:  1979-83 1984-88 1989-93 1994-98 All years 1979-98 
Type of 
surgery 
DVT 
(n) 
All dis-
charges 
% 
with 
DVT 
DVT 
(n) 
All dis-
charges
% 
with 
DVT
DVT 
(n) 
All dis-
charges
% 
with 
DVT
DVT 
(n) 
All dis-
charges 
% 
with 
DVT
DVT 
(n) 
All dis-
charges
% 
with 
DVT 
X2 with 3 df for 
surgical group, all 
years 
Tumour 5 557 0. 9 19 665 2.9 14 719 2.0 28 674 4.2 66 2615 2.5 15.54, P<0.010 
Vascular 5 353 1.4 8 352 2.3 20 454 4.4 61 615 9.9 94 1774 5.3 43.91, P<0.001 
Trauma 3 452 0.7 7 549 1.3 6 451 1.3 18 349 5.2 34 1801 1.9 25.67, P<0.001 
Spinal 4 633 0.6 16 670 2.4 9 775 1.2 23 653 3.5 52 2731 1.9 17.77, P<0.001 
Other 4 632 0.6 8 593 1.4 9 579 1.6 30 677 4.4 51 2481 2.1 27.52, P<0.001 
No 
surgery 
8 1873 0.4 3 2146 0.1 8 1818 0.4 15 1863 0.8 34 7700 0.4 10.06, P<0.025 
X2 5 df 5.23*, P<0.500 46.26*, P<0.001 44.57, P<0.001 16.38, P<0.010 219.73, P<0.001  
Total 29 4500 0.6 61 4975 1.2 66 4796 1.4 175 4831 3.6 331 19102 1.7  
 
* some cells of χ2 analysis contain expected values <5.0 
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Table 3.2.7.3 – Distribution of PE by surgical group in five-year periods: 1979-98 
 
Year of discharge:  1979-83 1984-88 1989-93 1994-98 All years 1979-98 
Type of 
surgery 
PE 
(n) 
All dis-
charges 
% 
with 
PE 
PE 
(n) 
All dis-
charges
% 
with 
PE 
PE 
(n) 
All dis-
charges
% 
with 
PE 
PE (n)
All dis-
charges
% with 
PE 
PE 
(n) 
All dis-
charges 
% with 
PE 
X2 with 3 df 
for surgical 
groups-all 
years 
Tumour 6 557 1.1 6 665 0.9 6 719 0.8 12 674 1.8 30 2615 1.2 3.38, P<0.500 
Vascular 7 353 2.0 3 352 0.9 11 454 2.4 18 615 2.9 39 1774 2.2 4.67, P<0.250 
Trauma 4 452 0.9 0 549 0.0 5 451 1.1 3 349 0.9 12 1801 0.7 5.54*, P<0.250 
Spinal 0 633 0.0 5 670 0.8 12 775 1.6 11 653 1.7 28 2731 1.3 11.96, P<0.010 
Other 4 632 0.6 1 593 0.2 4 579 0.7 6 677 0.9 15 2481 0.6 2.85*, P<0.500 
No 
surgery 
6 1873 0.3 0 2146 0.0 4 1818 0.2 7 1863 0.4 17 7700 0.2 7.62*, P<0.100 
X2 5 df 20.35*, P<0.010 24.44*, P<0.001 26.09*, P<0.001 30.75*, P<0.001  89.54, P < 0.001  
Total 27 4500 0.6 15 4975 0.3 42 4796 0.9 57 4831 1.2 141 19102 0.7  
 
* some cells of χ2 analysis have expected values < 5.0 
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3.2.8 Incidence of DVT and PE according to Surgeon 
The preliminary analyses of DVT and PE distributions for individual surgeons are 
shown in Figs. 3.2.8.1 and 3.2.8.2. 
  
The notable change in pattern of incidence of DVT and PE at around 1992, already 
seen in Fig. 3.1.1, is again seen here.  Surgeon 3 provides a link between the more 
stable activity before 1991 and the more widely ranging activity after 1992.  Factors 
Fig. 3.2.8.1: Distribution of DVT by year for 
individual surgeons
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
19
76
-77
19
78
-79
19
80
-81
19
82
-83
19
84
-85
19
86
-87
19
88
-89
19
90
-91
19
92
-93
19
94
-95
19
96
-97
19
98
-99
Year of Discharge
In
ci
de
nc
e 
of
 D
VT
 (%
) Surgeon 1
Surgeon 2
Surgeon 3
Surgeon 4
Surgeon 5
Surgeon 6
Surgeon 7
Fig. 3.2.8.2: Distribution of PE by year for individual 
surgeons
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which changed during his term, or his management pattern, may be important for 
determining what has caused the increase in DVT and PE incidence.  
 
Distribution of diagnostic groups according to surgeon is shown in Table 3.2.8.1.  
There are some duplicate codes in this table- the total of 19175 is 73 more than the 
total discharges for the period. 
 
Table 3.2.8.1- Distribution of diagnostic group by Surgeon: 
 1979 - 98 
 
Surgeon & 
period recorded 
in data base 
Tumour 
(n) 
Vascular 
(n) 
Trauma 
(n) 
Spinal 
(n) 
Other 
(n) 
Total (n) 
Surgeon 1: 
1976-87 
735  
541 
  
1609 
 
1111 
 
316  4312 
Surgeon 2: 
1976-92 
1002 985 2304 1126 679 6096 
Surgeon 3: 
1988-present 
689 384 1026 1572 248 3919 
Surgeon 4: 
1992- present 
142 1316 429 41 159 2087 
Surgeon 5: 
1993- present 
540 178 384 190 137 1429 
Surgeon 6: 
1993-present 
226 107 273 197 249 1052 
Surgeon 7: 
1998- present 
63 92 78 67 10 280 
Totals (n) 3397 3573 6103 4304 1798 19175 
 
χ² with 24 DF for all groups 4674.88, P<0.001. 
 
Individual surgeons’ specialisations are apparent in this table.  For example, 
Surgeon 4 has treated more vascular cases than any other surgeon, and vascular is 
his highest volume group.  Surgeon 3, however, has treated more spinal cases, and 
spinal is his highest volume group.  Other surgeons’ practices are more widely 
spread across the types of surgery.  Overall, trauma is the highest volume group. 
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Distribution of DVT by surgeon is shown in Table 3.2.8.2.  χ2 calculations were not 
run for comparisons between surgeons in individual four-year groups, because the 
surgeons are not represented within all the year groups.  Surgeon 4, whose work is 
predominantly vascular, has the highest incidence of DVT at 4.7% of his discharges 
throughout his career.  Surgeon 7, who also has a high proportion of vascular cases, 
follows with 4.3%.  As is expected from the earlier Chart 3.1.1, the earlier Surgeons 
1 and 2 display a low rate, which doubles by 1984-88 for Surgeons 1,2 and 3. This 
rate remains low for Surgeons 2,3 and 5 (Surgeon 1 has by this time retired) for 
1989-93.  The rate rises to around 2.8% for Surgeons 3,5 and 6, but to 5.4% for 
Surgeon 4 and 4.3% for Surgeon 7 during 1994-98.  There appear to be two 
patterns in this table- a steady rise for Surgeons 1, 2, 3, 5 and 6 at similar rates, but 
a greater rate for Surgeons 4 and 7.   
 
The pattern of PE distribution (Table 3.2.8.2) differs from the DVT pattern seen in 
Table 3.2.8.1.  The expected rise can be seen, from around 0.7% in the early years 
to around 2.8% in 1994-98. However while Surgeon 4 has the highest rate in 1989-
93, Surgeons 6 and 7 have the highest rate by 1994-98.  Over all time, Surgeons 4 
and 7 have the highest rate at 1.4% and 2.1% respectively.
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Table 3.2.8.2 - Distribution of DVT by surgeon in five-year periods: 1979-98 
 
Discharge year:             1979-83 1984-88 1989-93 1994-98 All years 1979-98 
 
With 
DVT 
(n) 
Total 
(n) 
% 
with 
DVT 
With 
DVT 
(n) 
Total 
(n) 
% 
with 
DVT 
With 
DVT 
(n) 
Total 
(n) 
% 
with 
DVT 
With 
DVT 
(n) 
Total 
(n) 
% 
with 
DVT 
With 
DVT 
(n) 
Total 
(n) 
% with 
DVT 
Surgeon 1 17 2415 0.7 25 1903 1.3 0 0 0 0 0 0 42 4318 1.0 
Surgeon 2 12 2085 0.6 29 2515 1.2 17 1494 1.1 0 0 0 58 6094 1.0 
Surgeon 3 0 0 0 7 557 1.3 26 2420 1.1 26 945 2.8 59 3922 1.5 
Surgeon 4 0 0 0 0 0 0 22 673 3.3 76 1414 5.4 98 2087 4.7 
Surgeon 5 0 0 0 0 0 0 1 140 0.7 34 1207 2.8 35 1347 2.6 
Surgeon 6 0 0 0 0 0 0 0 69 0 27 983 2.8 27 1054 2.6 
Surgeon 7 0 0 0 0 0 0 0 0 0 12 280 4.3 12 280 4.39 
X2 6 df              166.25*, P<0.001 
All 
surgeons 
29 4500 0.6 61 4975 1.2 66 4796 1.4 175 4831 3.6 331 19102 1.7 
 
* 1 cell with expected value < 5.0 
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Table 3.2.8.3 – Distribution of PE by surgeon in five-year periods: 1979-98 
 
Discharge year: 1979-83 1984-88 1989-93 1994-98 All years 1979-98 
 
With 
PE (n) 
All 
discharges 
(n) 
% 
with 
PE 
With 
PE (n)
All 
discharges 
(n) 
% with 
PE 
With 
PE 
(n) 
All 
discharges 
(n) 
% 
with 
PE 
With 
PE 
(n) 
All 
discharges 
(n) 
% 
with 
PE 
With 
PE (n)
All 
discharges 
(n) 
% with 
PE  
Surgeon 1 15 2415 0.6 5 1903 0.3 0 0 0.0 0 0 0.0 20 4318 0.5 
Surgeon 2 12 2085 0.6 6 2515 0.2 5 1494 0.3 0 0 0.0 23 6094 0.4 
Surgeon 3 0 0 0.0 4 557 0.7 26 2420 1.1 10 945 1.1 40 3922 1.0 
Surgeon 4 0 0 0.0 0 0 0.0 11 673 1.6 18 1414 1.3 29 2087 1.4 
Surgeon 5 0 0 0.0 0 0 0.0 0 140 0.0 10 1207 0.8 10 1347 0.7 
Surgeon 6 0 0 0.0 0 0 0.0 0 69 0.0 13 985 1.3 13 1054 1.2 
Surgeon 7 0 0 0.0 0 0 0.0 0 0 0.0 6 280 2.1 6 280 2.1 
X2 6df              42.68*, P<0.001 
Totals 27 4500 0.6 15 4975 0.3 42 4796 0.9 57 4831 1.2 141 19102 0.7 
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3.3  SUMMARY OF RESULTS 
χ2 values for the potential predictors are summarised in Table 3.3.1. 
 
Table 3.3.1 -  χ2 values for the potential predictors of DVT and PE:  
1979-98 
 
Predictor χ2 for DVT χ2 for PE 
Significant 
increase over 
time in DVT (3df)
Significant 
increase over 
time in PE (3 df) 
Period 141.08 3df 28.22 3df χ2MH = 114.20 
P <0.001 
χ2MH= 17.94 
P <0.001 
Age 58.57 
P<0.001 
34.28 
P<0.001 
In all age groups In 0 age groups 
Sex 0.18 
P<0.75 
1.01 
P<0.90 
Not done Not done 
Month of 
admission 
8.67  11df 
P=0.65 
11.79 11 df 
P=0.38 
0.56 (P=0.45) 0.10 
(P=0.75) 
LOS 839.84 
P<0.001 
387.00 
P<0.001 
In all LOS groups In 3 out of 5 LOS 
groups 
Diagnostic 
group 
78.05 
P<0.001 
46.42 
P<0.001 
In 4 out of 5 
diagnostic groups 
In 2 out of 5 
diagnostic groups
Surgical 
group 
219.73 
P<0.001 
89.54 
P<0.001 
In 4 out of 5 
surgical groups 
In 1 out of 5 
surgical groups 
Surgeon 166.25* 
P<0.001 
42.68* 
P<0.001 
Not done Not done 
 
* some cells of χ2 test have expected values <5.0 
 
It has been shown in Table 3.1.2 that there is a significantly increasing trend over 
time in the incidence of both DVT and PE.  There are also significantly increasing 
trends in the number of patients undergoing surgery and in the mean age of patients 
(Table 3.2.1).  However there are declines in mean LOS and the proportion of 
males.  The distribution pattern of diagnostic and surgical groups fluctuates, as does 
the presence of a variety of surgeons with their individual practice patterns.  
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Table 3.3.1 suggests that the strongest predictors of both DVT and PE are LOS and 
surgical group, although the relationships are weaker for PE than for DVT.   
Another factor to be considered is time. Over the twenty years under consideration, 
vascular and trauma diagnostic groups show significantly different incidences of 
DVT.  Spinal is the only diagnostic group showing significantly different incidences 
of PE over time.  LOS and age have the strongest association with DVT over time, 
and LOS has the strongest association with PE over time. 
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3.4  FURTHER EXPLORATION OF PREDICTORS OF DVT AND PE USING 
MULTIVARIATE LOGISTIC REGRESSION 
 
3.4.1 DVT as outcome variable with surgeon, diagnostic and operation                     
           groups 
 
Results are tabulated below. 
 
Table 3.4.1.1 -  DVT as outcome – logistic regression analysis results – 
base model 
 
Variables in 
model- DVT as 
outcome 
χ2 for 
model* 
 (-2LnL) 
Signific- 
ance test 
for addition 
of 
variable(s) 
to model 
(P) 
P for each added 
variable 
OR for each 
added variable 
(95% C.I.) 
LOS 206.4  1df  <0.001 1.02 (1.02-1.02) 
LOS 
LOSgp 
 
314.7  2df 
 
108.3 1df  
(<0.001) 
 
<0.001 
 
0.08 (0.05-0.14) 
LOS  
LOSgp  
periods 
 
 
507.5  5df 
 
 
192.8 (3 df) 
(<0.001) 
 
 
 
1979-83: n.a 
1984-88: <0.001 
1989-93: <0.001 
1994-98: <0.001 
 
 
 
1.0* 
2.52 (1.57-4.03) 
3.33 (2.11-5.26) 
9.98 (6.56-15.18) 
LOS 
LOSgp  
periods  
age (Base 
model) 
 
 
548.1  6df 
   
 
 
40.6 (1df) 
(<0.001) 
 
 
<0.001 
 
 
1.02 (1.01-1.03) 
LOS 
LOSgp  
periods  
age  
agegp 
 
 
 
555.0  7df 
    
 
 
  
6.9 (1df) 
(<0.01) 
 
 
 
0.017 
 
 
 
0.44 (0.23-0.87) 
* reference group 
 
Logistic regression analysis showed that agegp was not a significant variable for 
inclusion in the model so it was excluded.  A base model was thus obtained: 
 DVT/1 = LOS + LOSgp + periods + age. 
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Addition of further dummy variable groups separately to the base model gave the 
following results: 
 
Table 3.4.1.2 - DVT as outcome- logistic regression results- addition of further 
dummy variables 
 
Variables in 
model- DVT as 
outcome 
χ2 for  
model
* 
Signific- 
ance test for 
addition of 
variable(s) to 
model (P) 
P for each 
added variable 
OR for each 
added variable 
(95% C.I.) 
LOS  
LOSgp  
periods  
age  
vmos 576.4 
12 df  
28.3 6df 
(<0.001) 
 
 
 
 
Vmo1: n.a. 
Vmo2: 0.97 
Vmo3: 0.42 
Vmo4: 0.05 
Vmo5: 0.79 
Vmo6: 0.70 
Vmo7: 0.22 
1.0** 
0.99 (0.63-1.56) 
0.77 (0.41-1.44) 
1.99 (1.01-3.90) 
1.11 (0.52-2.33) 
1.17 (0.54-2.52) 
1.76 (0.72-4.33) 
LOS  
LOSgp  
periods  
age  
diagps 
 
590.4  
10 df 
 
42.3 4df 
(<0.001) 
 
 
 
 
Diagp1: <0.001 
Diagp2: <0.001 
Diagp3:   0.021 
Diagp4:   0.27 
Diagp5:   n.a. 
2.19 (1.53-3.14) 
2.58 (1.86-3.58) 
1.48 (1.06-2.07) 
1.23 (0.85-1.79) 
1.0** 
LOS  
LOSgp  
periods  
age  
opngps 658.6  
11 df 
113.7 5df 
(<0.001) 
 
 
 
 
No op:    n.a. 
Opngp1: <0.001 
Opngp2: <0.001 
Opngp3: <0.001 
Opngp4: <0.001 
Opngp5: <0.001 
 
1.0** 
2.64 (1.93-3.61) 
2.84 (2.10-3.84) 
1.95 (1.34-2.84) 
1.64 (1.32-2.38) 
2.30 (1.78-2.95) 
 
 
*χ2 for model = difference between intercept and intercept with variable terms. 
** reference term   
 
Addition of the vmo, diagp and opngp variables in the equation together yielded  
collinear results such that the standard errors for these variables were larger when 
the variables were run together in the regression model, indicating a loss of 
precision for this model.  This was already implied in Table 3.2.8.1, which shows 
that diagnoses are spread across all the surgeons, albeit unevenly.  It is known also 
that all surgeons have a mix of operations, however the surgeons tend to 
subspecialise, producing some collinearity between surgeon, diagnosis and 
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operation. The most important source of collinearity, however, is surgeon by 
periods, as can be seen in Table 3.2.8.2. 
The equation of best fit is the one including the base model and operation group 
terms, with P for this model remaining the most highly significant at <0.001. It is 
concluded that while surgeon and diagnosis are associated with increased incidence 
of DVT, operation group is most highly associated with DVT, after allowing for length 
of stay, period and age.   P values for all operation variables are significant. 
  
3.4.2 DVT as outcome variable with individual diagnoses 
  Diagnoses from the database ordered by decreasing incidence of DVT are shown 
in Table 3.4.2. 
Table 3.4.2  - Individual diagnoses in descending order of DVT incidence 
  
DIAGNOSIS 
Total with 
diagnosis 
(n) 
DVT 
(n) % DVT
Cerebral meningioma 403 38 9.4 
Vertebro-basilar aneurysm  149 12 8.05 
Admission due to anticoagulant therapy (Aspirin, 
Warfarin,Heparin) 141 11 7.8 
Spontaneous intraventricular haemorrhage 456 31 6.8 
Spinal unit patient 332 21 6.33 
Acute spinal trauma  573 36 6.28 
Posterior communicating artery aneurysm 245 15 6.12 
Anterior communicating artery aneurysm 385 23 5.97 
Posterior fossa haemorrhage 17 1 5.88 
Middle cerebral artery aneurysm 344 20 5.81 
Spontaneous subarachnoid haemorrhage 1014 57 5.62 
Vascular injury 18 1 5.56 
Arteriovenous malformation including venous 
angioma, cavernous haemangioma, cavernoma 554 27 4.96 
Intraventricular haemorrhage 123 6 4.88 
Spontaneous intracerebral haemorrhage 829 40 4.83 
Cerebral oligodendroglioma 44 2 4.5 
Pineal gland tumour 24 1 4.2 
Spinal abscess, myelitis, discitis 25 1 4 
Other infections 177 7 3.95 
Aqueduct stenosis 52 2 3.85 
Aneurysm at other cerebral location 366 14 3.83 
Craniopharyngioma 54 2 3.7 
Hydrocephalus 443 15 3.39 
CSF fistula / aerocoele 148 5 3.38 
Intradural tumour 164 5 3.05 
Facial hemispasm 33 1 3.03 
Cerebral extradural haematoma 462 14 3.03 
Cerebral abscess 186 5 2.69 
Intracerebral haemorrhage 558 14 2.51 
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DIAGNOSIS 
Total with 
diagnosis 
(n) 
DVT 
(n) % DVT
Head Injury (LOS> 4 Days) 1486 35 2.36 
Extradural tumour  403 9 2.23 
Cerebral metastasis 446 10 2.2 
Transient ischaemic attack / amaurosis fugax 102 2 1.96 
Other intracerebral tumour 107 2 1.9 
Subdural haematoma 1471 28 1.9 
Syringomyelia 106 2 1.89 
Cerebral high grade astrocytoma 846 14 1.8 
Acoustic neuroma 120 2 1.7 
Cerebral infarct /C.V.A 244 4 1.64 
Other vascular e.g.cerebral ischaemia 184 3 1.63 
Carotico-cavernous fistula 66 1 1.52 
Spinal stenosis 528 8 1.52 
Meningitis 67 1 1.49 
Other spinal, e.g. arachnoiditis, AVM, 
spondylolisthesis 781 11 1.41 
Cerebral astrocytoma of unknown grade 70 1 1.4 
Parkinson's disease 83 1 1.2 
Vascular dissection 89 1 1.12 
Other peripheral nerve diagnoses  96 1 1.05 
Spondylosis 384 4 1.04 
Carotid, vertebal, basilar artery stenosis 199 2 1.01 
Other diagnoses e.g. intracranial cyst, fitting for 
investigation 964 9 0.93 
Compound / depressed skull fracture 465 4 0.86 
Other CSF circulation diagnoses 128 1 0.78 
Pituitary tumour 421 3 0.7 
Epilepsy 159 1 0.63 
Intervertebral disc lesion  970 6 0.62 
Cerebral low grade astrocytoma 219 1 0.5 
Spinal pain of undetermined origin 296 1 0.34 
Carpal tunnel compression 782 1 0.13 
Head injury (LOS< 4 Days) 1911 2 0.1 
Peripheral nerve injury 5 0 0 
Cranial nerve injury 7 0 0 
Thoracic inlet compression 7 0 0 
Medulloblastoma 9 0 0 
Cerebral haemangioma 11 0 0 
Encephalitis 20 0 0 
Cerebral ependymoma 22 0 0 
Colloid Cyst 24 0 0 
Osteoma, mucocoele of sinus 28 0 0 
Miscellaneous neurofibroma, not acoustic neuroma 29 0 0 
Blocked shunt 42 0 0 
Facial paralysis 44 0 0 
Ulnar nerve compression 46 0 0 
Peripheral nerve tumour 46 0 0 
Cerebral haemangioblastoma 47 0 0 
"Normal pressure" hydrocephalus 58 0 0 
Other cranial nerve diagnoses 67 0 0 
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DIAGNOSIS 
Total with 
diagnosis 
(n) 
DVT 
(n) % DVT
Meralgia paraesthetica 67 0 0 
Infected craniotomy site 72 0 0 
Cerebral palsy 93 0 0 
Intractable pain 106 0 0 
Spontaneous posterior fossa haemorrhage 113 0 0 
Skull defect 132 0 0 
Cerebral lymphoma 133 0 0 
Headache for investigation 282 0 0 
Trigeminal neuralgia 287 0 0 
Arnold chiari malformation 479 0 0 
 
Replacement of diagnosis groups by the individual high-DVT diagnoses gave a 
significance test (-2LnL) for the model of 577.0, less than 590.4 (p<0.001) for the 
model with diagnosis group variables.  P values for inclusion of these diagnosis 
variables in the model are shown in the table below. 
 
Table 3.4.2.1 – DVT as outcome – logistic regression results –substitution of 
individual high-DVT diagnoses in the model   
Diagnosis variable P Odds Ratio (95% C.I) 
Meningioma <0.001 3.01 (2.03 - 4.48) 
Intraventricular bleed 0.014 2.43 (1.20 – 4.94) 
Posterior communicating a. aneurysm 0.25 1.73 (0.68 – 4.43) 
Vertebro-basilar aneurysm 0.43 1.49 (0.56 – 3.97) 
Spinal trauma 0.79 1.17 (0.69 – 1.98) 
All other diagnoses  1.0* 
* reference group  
 
Only one diagnosis (meningioma) had a significant P value of <0.001.  Thus it 
appears that a better prediction is given for the incidence of DVT by using the “a 
priori” diagnosis groups of Table 3.4.1.2 than the five highest incidence diagnoses.  
This may be because the diagnosis groupings were more successful at 
discriminating within the heterogeneity of the reference group “all other diagnoses” 
used in Table 3.4.2.1 above.   A more predictive model might be had by including 
more of the high-DVT diagnoses, but that is outside the scope of this work.  
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3.4.3 DVT as outcome with individual operations  
 
Operations and some procedures from the database ordered by decreasing 
incidence of DVT are shown in Table 3.4.3. 
 
Table 3.4.3 - Individual operations in descending order of DVT 
incidence 
Procedure 
Total 
having 
procedure 
No. 
with 
DVT 
% with 
DVT 
Balloon angioplasty  17 4 23.53
Papaverine angiogram 163 32 19.63
Barbiturate coma 99 18 18.18
Calf muscle stimulation** 51 7 13.73
Embolization of tumour 18 2 11.11
Craniotomy for evacuation of spontaneous 
intracerebral haematoma 
366 38 10.38
I/O external ventricular drain 1613 167 10.35
Return to operating theatre for re-opening of  
craniotomy (haematoma, oedema etc) 
336 31 9.23
Craniotomy for E/O arterio-venous malformation 272 23 8.46
I/O ventriculo-peritoneal shunt 458 37 8.08
Transsphenoidal exploration 13 1 7.69
Posterior lumbar interbody fusion 14 1 7.14
Craniotomy clip aneurysm                                            936 62 6.62
Return to operating theatre for wound revision / 
resuture 
224 14 6.25
Burr hole for aspiration of cerebral abscess 48 3 6.25
Tracheostomy 568 35 6.16
Other operations for CSF circulation disorders; 
includes ventriculostomy, exploration of shunt, I/O 
Rickham reservoir 
164 10 6.10
Closed reduction cervical fracture dislocation, 
including application of Botterill calipers, Gardner 
Wells tongs 
122 7 5.74
Other vascular procedure, includes ligation CCA for 
aneurysm, craniotomy & exploration, occipital artery 
biopsy, burr hole biopsy haematoma, lobectomy for 
aneurysm  
129 7 5.43
Craniotomy evacuation traumatic haematoma 745 37 4.97
Embolization of vascular lesion 167 8 4.79
Cranioplasty 231 11 4.76
Craniotomy exploration for tumour 21 1 4.76
Thoracic, lumbar posterior stabilisation, including I/O 
screws, rods, rectangles, plates 
229 10 4.37
Burr hole evacuation spontaneous intracerebral 
haematoma 
71 3 4.23
Craniotomy wrap aneurysm 24 1 4.17
I/O ventriculo-atrial shunt 50 2 4.00
Other trauma, includes burr hole exploration 156 6 3.85
Craniotomy for partial excision of tumour  579 22 3.80
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Procedure 
Total 
having 
procedure 
No. 
with 
DVT 
% with 
DVT 
Extracranial – intracranial vascular bypass 80 3 3.75
Sacral laminectomy 54 2 3.70
Repair C.S.F. fistula,  aerocoele /dural repair 138 5 3.62
Craniotomy for total excision of tumour 1081 39 3.61
Anterolateral spinal decompression involving 
thoracotomy, with / without anterior fusion 
84 3 3.57
Craniotomy for E/O cerebral abscess 60 2 3.33
Thoracic laminectomy, includes exposure for other 
procedures 
312 9 2.88
Posterior complex cervical fusion (includes I/O 
screws, plates) 
37 1 2.70
Frameless stereotactic e/o cerebral tumour 43 1 2.33
Craniotomy biopsy of tumour 133 3 2.26
Cervical laminectomy 269 6 2.23
Other spinal procedure, includes biopsy of cord, 
excision cervical rib, intrathecal injection, 
cordectomy, excision spinal angioma or tumour, 
vertebrectomy, R/O spinal hardware  
541 11 2.03
Burr hole evacuation traumatic haematoma 737 14 1.90
Other miscellaneous procedures, includes temporal 
artery biopsy, R/O wires from old craniotomy, D/O 
intracranial cyst 
223 4 1.79
Operations for syrinx 56 1 1.79
Lumbar laminectomy, includes exposure for other 
procedures 
758 13 1.72
Other cranial nerve operation including canthoplasty, 
balloon compression, alcohol injection 
61 1 1.64
Anterior cervical fusion, stabilisation, including 
application of plates 
556 9 1.62
Elevation /repair of depressed/compound skull 
fracture 
252 4 1.59
Posterior simple cervical fusion (wiring) 135 2 1.48
Exploration of spine 72 1 1.39
Stereotactic burr hole biopsy of tumour 216 3 1.39
Shunt revision 162 2 1.23
Other procedure for infectious condition, includes 
biopsy 
87 1 1.15
Discectomy 508 5 0.98
Burr hole biopsy of tumour 205 2 0.98
Other procedures for cerebral tumour 135 1 0.74
Peripheral nerve decompression 162 1 0.62
No operation 7723 35 0.45
Transsphenoidal excision of pituitary tumour 310 1 0.32
I/o spinal Baclofen pump 26 0 0.00
I/o Ommaya reservoir for chemotherapy 128 0 0.00
Pallidotomy/thalamotomy 105 0 0.00
I/O other shunts, including lumbo-peritoneal, spino-
pleural, syringo-pleural 
27 0 0.00
Other peripheral nerve procedures, including ulnar 
nerve transposition, E/O tumour, exploration, biopsy, 
201 0 0.00
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Procedure 
Total 
having 
procedure 
No. 
with 
DVT 
% with 
DVT 
nerve block, division 
Foraminotomy  66 0 0.00
Needle biopsy of vertebra  28 0 0.00
Posterolateral spinal decompression 
(costotransversectomy), with/without posterior fusion
9 0 0.00
Open reduction dislocated spine (cervical – sacral) 53 0 0.00
Microdiscectomy 48 0 0.00
Facio-hypoglossal anastomosis 37 0 0.00
Thermocoagulation for cranial neuropathy 89 0 0.00
Neurotomy/neurectomy (Frazier's operation) for 
cranial neuropathy 
61 0 0.00
Janetta procedure (microvascular decompression of 
cranial nerve) 
143 0 0.00
R/o cranioplasty plate 54 0 0.00
Vascular graft other than extra-intracranial bypass 18 0 0.00
Endarterectomy  94 0 0.00
**Calf muscle stimulation, a procedure designed to prevent DVT, is no longer 
recorded in the database as its use in the hospital has not been consistent over 
time.   
  
Tables 3.4.3 and 3.4.6 should be read with the following points in mind:  
1. Many of the individual operations quoted are only a part of a multiple procedure, 
such as lumbar laminectomy for removal of a spinal cord tumour.  This places a 
limitation on interpreting these figures.  
2. One admission may include several operations; for example, some operations 
for insertion of ventriculoperitoneal shunt are performed on patients with 
hydrocephalus, which has resulted from an intracranial subarachnoid 
haemorrhage.  Most of these patients have already undergone clipping of an 
aneurysm, insertion of an external ventricular drain, and several cerebral 
angiograms earlier in their admission.  
3. The procedure with the highest incidence of DVT is Barbiturate coma, which is 
only induced in patients who are already gravely ill with cerebral oedema.  It is 
uncertain whether the high rate of DVT in these patients is due to their comatose 
state or to any of the other conditions they may have.  That is, it may be due to 
the complexity of their illness.  Tracheostomy, performed for ill patients with 
respiratory difficulties, is another such procedure.   
4. Small numbers of incidences of DVT and of procedures are not meaningful, but 
are included to give a broad picture of the surgical activity recorded in the 
database.   
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5. Because the database has been collecting information over the last twenty 
years, some types of procedures have changed in frequency since the early 
years.  For example, operative techniques have improved to the point where 
ligation of carotid arteries is no longer performed for aneurysm patients.  
Papaverine angiography and balloon angioplasty have been in use only since 
1992 and 1997 respectively, so they are not distributed across the whole 
database. 
The model with individual operations gave a test statistic (-2LnL) of 665.4, more 
than 658.6 for the model with operation group variables.   
P values, odds ratios and 95% confidence intervals for inclusion of these operation 
variables in the model are shown in the table below. 
 
Table 3.4.3.1 - DVT as outcome – logistic regression results –substitution of 
individual high-DVT procedures in the model 
 
Operation (procedure) variable P Odds Ratio  (95% C.I) 
Insertion external ventricular drain 0.001 3.22  (2.43 – 4.28) 
Craniotomy for arteriovenous 
malformation 
0.001 2.35   (1.40 – 3.96) 
Unplanned return to theatre for reopening 
craniotomy  
0.004 2.00   (1.26 – 3.18) 
Unplanned return to theatre for wound 
revision  
0.30 1.51 (0.69 – 3.33) 
Craniotomy for clipping aneurysm 0.051 1.40  (1.00 – 1.97) 
Craniotomy for spontaneous intracerebral 
haematoma  
0.65 1.13  (0.67 – 1.92) 
All other operations and those with no 
operation* 
n.a. 1.0* 
* reference group 
 
It appears that an improvement in fit of the model is gained by substituting individual 
high-DVT operations for the operation groups.  Four of the six high-DVT variables 
had highly significant P  values, indicating the greater precision of selection of 
variables for inclusion in the model, and represent data collected over the full twenty 
years.  Angiography and thiopentone coma data were collected over only the last 
four years.
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3.4.4  PE as outcome with diagnosis and operation groups 
Table 3.4.4.1 - PE as outcome- logistic regression analysis results- base 
model 
 
Variables in 
model- PE as 
outcome 
χ2 for  
model 
(-2LnL) 
Significance 
test for 
addition of 
variable(s) 
to model 
P for each added 
variable 
OR for each 
added variable 
(95% C.I.) 
 
LOS 78.5    1df  <0.001 1.02 (1.01-1.02) 
LOS  
LOSgp  92.1    2 df 
 
13.6    1 df 
P<0.001 
<0.001 0.27 (0.13-0.58) 
LOS 
LOSgp  
periods  
 
 
134.3   5df 
 
 
42.2    3df 
P<0.001 
 
 
1979-83: n.a. 
1984-88: 0.080 
1989-93: 0.020 
1994-98: 0.003 
1.0* 
0.55  (0.28-1.09) 
1.97  (1.19-3.25) 
2.81  (1.74-4.54) 
LOS  
LOSgp  
periods  
age (base 
model) 
 
 
169.0   6df 
 
 
 
35.7    1 df 
P<0.001 
 
 
<0.001 
 
 
1.03  (1.02-1.04) 
LOS  
LOSgp  
periods  
age  
agegp 
 
 
 
 
173.3   7df 
 
 
 
 
4.3      1df 
P>0.025 
 
 
 
0.063 
 
 
 
0.41 (0.16-1.05) 
*reference group 
 
It can be seen that agegp was not a significant variable for inclusion in this model, 
and the confidence intervals for its odds ratio lie on either side of 1.0, so it was 
excluded from the model.  Although period2 appears not to be significant, in the 
above models, it must be retained as it is part of a set of dummy variables, the rest 
of which are significant overall.   
Similarly to DVT, the base model is:  PE/1 = LOS LOSgp periods age. 
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Addition of further dummy variables to the base model gave the following results: 
 
Table 3.4.4.2 – PE as outcome – logistic regression results- addition of further 
variables 
 
Variables in 
model- PE as 
outcome 
χ2 for 
model  
(-2LnL) 
Signific-
ance test 
for addition 
of 
variable(s) 
to model 
(P) 
P for each 
added  variable 
O.R. for added 
variables (95% C. I.) 
LOS  
LOSgp  
periods  
age  
vmos 
 
 
 
 
182.5  12df 
 
 
 
 
13.5     6df 
(<0.025) 
 
 
 
 
 
Vmo1: n.a. 
Vmo2: 0.74 
Vmo3: 0.78 
Vmo4: 0.026 
Vmo5: 0.37 
Vmo6: 0.056 
Vmo7: 0.017 
 
 
 
 
1.0* 
0.90  (0.46 – 1.74) 
2.28  (0.91 – 5.69) 
3.15  (1.15 – 8.67) 
1.71  (0.53 – 5.47) 
3.02  (0.97 – 9.31) 
4.81  (1.32 - 17.52) 
LOS  
LOSgp  
periods  
age  
diagps 
 
 
 
 
200.9  10df 
 
 
 
 
31.9  4df 
(<0.001) 
 
 
 
 
Diagp1: <0.001 
Diagp2: <0.001 
Diagp3: 0.94 
Diagp4: 0.017 
Diagp5: n.a.  
 
 
 
 
2.54 (1.49 – 4.33) 
3.49 (2.12 – 5.73) 
0.98 (0.56 – 1.70) 
1.92 (1.12 – 3.29) 
1.0* 
Age  
LOS  
LOSgp  
periods  
age  
opngps 212.8  12df 43.8  7df 
(<0.001) 
 
 
 
 
 
Opngp1:<0.001 
Opngp2:<0.001 
Opngp3: 0.078 
Opngp4: 0.007 
Opngp5: 0.074 
Opngp6: 0.46 
 
 
 
2.69 (1.70 – 4.26) 
3.77 (2.40 – 5.93) 
1.72 (0.94 – 3.14) 
2.03 (1.21 – 3.40) 
1.42 (0.97 – 2.08) 
2.23 (0.26 – 19.01) 
*reference group 
 
The greatest increase is for addition of operation group terms.  It is concluded that 
while addition of diagnosis to the base model is associated with increased incidence 
of PE, surgeon is not.  However, operation is most highly associated with PE.   
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3.4.5  PE as outcome variable with individual diagnoses 
Diagnoses from the database ordered by decreasing incidence of PE are shown in 
Table 3.4.5. 
 
Table 3.4.5  Individual diagnoses in descending order of PE incidence 
 
DIAGNOSIS 
Total with 
diagnosis 
(n) 
PE (n) % PE 
Vascular injury 18 1 5.56 
Spinal unit patient 332 18 5.42 
Cerebral ependymoma 22 1 4.55 
Other intracerebral tumour 107 4 3.74 
Anterior communicating artery aneurysm 385 13 3.38 
Acute spinal trauma 573 18 3.14 
Carotico-cavernous fistula 66 2 3.03 
Vertebro-basilar aneurysm 149 4 2.69 
Middle cerebral artery aneurysm 344 9 2.62 
Cerebral meningioma 403 10 2.48 
Cerebral infarct /C.V.A 244 6 2.46 
Blocked shunt 42 1 2.38 
Cerebral oligodendroglioma 44 1 2.27 
Spontaneous intracerebral haemorrhage 829 17 2.05 
Aqueduct stenosis 52 1 1.92 
Craniopharyngioma 54 1 1.85 
Spontaneous subarachnoid haemorrhage 1014 17 1.68 
Other vascular e.g.cerebral ischaemia 184 3 1.63 
Cerebral abscess 186 3 1.61 
Cerebral metastasis 446 7 1.57 
Cerebral astrocytoma of unknown grade 70 1 1.43 
Admission due to anticoagulant therapy (Aspirin, 
Warfarin,Heparin) 141 2 1.42 
Intradural tumour 164 2 1.22 
Vascular dissection 89 1 1.12 
Aneurysm at other cerebral location 366 4 1.09 
Other spinal, e.g. arachnoiditis, spinal AVM, 
spondylolisthesis 781 8 1.02 
Extradural tumour 403 4 0.99 
Spontaneous intraventricular haemorrhage 456 8 0.95 
Spinal stenosis 528 5 0.95 
Acoustic neuroma 120 1 0.83 
Posterior communicating artery aneurysm 245 2 0.82 
Subdural haematoma 1471 12 0.82 
Intraventricular haemorrhage 123 1 0.81 
Skull defect 132 1 0.76 
Cerebral lymphoma 133 1 0.75 
Arteriovenous malformation including venous 
angioma, cavernous haemangioma, cavernoma 554 4 0.72 
CSF fistula / aerocoele 148 1 0.68 
Intracerebral haemorrhage 558 3 0.54 
Spondylosis 384 2 0.52 
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DIAGNOSIS 
Total with 
diagnosis 
(n) 
PE (n) % PE 
Carotid, vertebal, basilar artery stenosis 199 1 0.5 
Hydrocephalus 443 2 0.45 
Cerebral high grade astrocytoma 846 8 0.45 
Other diagnoses e.g. intracranial cyst, fitting for 
investigation 964 4 0.41 
Head Injury (LOS> 4 Days) 1486 6 0.4 
Intervertebral disc lesion 970 3 0.31 
Pituitary tumour 421 1 0.24 
Cerebral extradural haematoma 462 1 0.22 
Compound/depressed skull fracture 465 1 0.22 
Posterior fossa haemorrhage 17 0 0 
Pineal gland tumour 24 0 0 
Spinal abscess, myelitis, discitis 25 0 0 
Other infections 177 0 0 
Facial hemispasm 33 0 0 
Other CSF circulation diagnoses 128 0 0 
Transient ischaemic attack / amaurosis fugax 102 0 0 
Syringomyelia 106 2 0 
Meningitis 67 0 0 
Parkinson's disease 83 0 0 
Other peripheral nerve diagnoses 6 0 0 
Epilepsy 159 0 0 
Cerebral low grade astrocytoma 219 0 0 
Spinal pain of undetermined origin 296 0 0 
Carpal tunnel compression 782 0 0 
Head injury (LOS< 4 Days) 1911 0 0 
Cerebral haemangioblastoma 47 0 0 
Medulloblastoma 9 0 0 
Osteoma, mucocoele of sinus 28 0 0 
Miscellaneous neurofibroma, not acoustic neuroma 29 0 0 
Cerebral haemangioma 11 0 0 
Colloid Cyst 24 0 0 
Spontaneous posterior fossa haemorrhage 113 0 0 
Arnold chiari malformation 479 0 0 
Encephalitis 20 0 0 
Infected craniotomy site 72  0 
Trigeminal neuralgia 287 0 0 
Facial paralysis 44 0 0 
Cranial nerve injury 7 0 0 
Other cranial nerve diagnoses 67 0 0 
Ulnar nerve compression 46 0 0 
Thoracic inlet compression 7 0 0 
Meralgia paraesthetica 67 0 0 
Peripheral nerve tumour 46 0 0 
Peripheral nerve injury 5 0 0 
"Normal pressure" hydrocephalus 58 0 0 
Intractable pain 106 0 0 
Cerebral palsy 93 0 0 
Headache for investigation 282 0 0 
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When grouped diagnoses are replaced in the model with individual diagnoses with 
the highest incidence of PE, the significance test (-2LnL) was 200.8, similar to 205.6 
for the model with grouped diagnosis variables. P values for inclusion of these 
diagnosis variables in the model are shown in the table below. 
 
Table 3.4.5.1 - PE as outcome – logistic regression results –substitution of 
individual high-PE diagnoses in the model 
 
Diagnosis variable P Odds Ratio (95% C. I.) 
Anterior communicating a. aneurysm <0.001 3.55 (1.93  - 6.51)  
Cerebral infarct    0.008 3.12 (1.34 – 7.28) 
Middle cerebral a. aneurysm   0.009 2.60 (1.28 – 5.29) 
Spinal trauma   0.006 2.33 (1.28 – 4.25) 
Meningioma   0.035 2.04 (1.05 – 3.95) 
All other diagnoses   n.a. 1.0* 
* reference group 
 
The first four diagnoses are highly significant, with meningioma significant only to 
<0.05, although its confidence intervals lie above 1.0.   
 
3.4.6 – PE as outcome variable with individual operations 
 
Operations and some procedures from the database ordered by decreasing 
incidence of PE are shown in Table 3.4.6. 
 
Table 3.4.6 –Individual operations in descending order of PE incidence 
  
Procedure 
Total 
having 
procedure 
No. 
with 
PE 
% 
with 
PE 
Burr hole for aspiration of cerebral abscess 48 3 6.25
Balloon angioplasty  17 1 5.88
Embolisation of tumour 18 1 5.56
Papaverine angiography 163 8 4.91
Anterolateral spinal decompression involving 
thoracotomy, with / without anterior fusion 
84 4 4.76
Return to operating theatre for re-opening of  craniotomy 
(haematoma,oedema etc) 
336 15 4.46
I/O spinal Baclofen pump 26 1 3.85
I/O other shunts, including lumbo-peritoneal, spino-
pleural, syringo-pleural 
27 1 3.70
Other vascular procedure, includes ligation CCA for 
aneurysm, craniotomy & exploration, occipital artery 
129 4 3.10
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Procedure 
Total 
having 
procedure 
No. 
with 
PE 
% 
with 
PE 
biopsy, burr hole biopsy haematoma, lobectomy for 
aneurysm  
Thoracic, lumbar posterior stabilisation, including I/O 
screws, rods, rectangles, plates 
229 7 3.06
Barbiturate coma 99 3 3.03
Craniotomy for clipping aneurysm                                     936 26 2.78
I/O ventriculo-peritoneal shunt 458 12 2.62
I/O external ventricular drain 1613 42 2.60
Craniotomy evacuation spontaneous intracerebral 
haematoma 
366 9 2.46
Other operations for CSF circulation disorders; includes 
ventriculostomy, exploration of shunt, I/O Rickham 
reservoir 
164 4 2.44
Craniotomy for partial excision of tumour  579 13 2.25
Tracheostomy 568 12 2.11
Sacral laminectomy 54 1 1.85
Other miscellaneous, includes R/O wires from old 
craniotomy,  drainage intracranial cyst 
223 4 1.79
Craniotomy for E/O cerebral abscess 60 1 1.67
Thoracic laminectomy, includes exposure for other 
procedures 
312 5 1.60
Craniotomy for biopsy of tumour 133 2 1.50
Other procedures for cerebral tumour 135 2 1.48
Burr hole evacuation spontaneous intracerebral 
haematoma 
71 1 1.41
Exploration of spine 72 1 1.39
Burr hole evacuation traumatic haematoma 737 10 1.36
Other spinal, includes cord biopsy, excision cervical rib,  
cordectomy, excision spinal angioma or tumour, 
vertebrectomy, R/O spinal hardware  
541 7 1.29
Other trauma, includes burr hole exploration 156 2 1.28
Anterior cervical fusion, stabilisation, including plating 556 7 1.26
Extracranial – intracranial vascular bypass 80 1 1.25
Craniotomy for total excision of tumour 1081 13 1.20
Other procedure for infectious condition, includes biopsy 87 1 1.15
Craniotomy for arterio-venous malformation 272 3 1.10
Endarterectomy  94 1 1.06
Burr hole for biopsy of tumour 205 2 0.98
Stereotactic burr hole biopsy of tumour 216 2 0.93
Wound revision / resuture 224 2 0.89
Cranioplasty 231 2 0.87
Closed reduction of cervical fracture dislocation, 
including application of Botterill calipers, Gardner- Wells 
tongs 
122 1 0.82
I/O Ommaya reservoir for chemotherapy 128 1 0.78
Posterior simple cervical fusion (wiring) 135 1 0.74
Repair CSF fistula / aerocoele /dural repair 138 1 0.72
Lumbar laminectomy, includes exposure for other 
procedures 
758 5 0.66
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Procedure 
Total 
having 
procedure 
No. 
with 
PE 
% 
with 
PE 
Shunt revision 162 1 0.62
Embolisation of vascular lesion 167 1 0.60
Other peripheral nerve procedures, including ulnar nerve 
transposition, E/O tumour, exploration, biopsy, nerve 
block, division 
201 1 0.50
Elevation /repair depressed/compound skull fracture 252 1 0.40
Cervical laminectomy 269 1 0.37
Craniotomy evacuation traumatic haematoma 745 2 0.27
No operation 7723 16 0.21
Discectomy 508 1 0.20
Vascular graft other than extra-intracranial bypass 18 0 0.00
Transsphenoidal exploration 13 0 0.00
Transsphenoidal excision of pituitary tumour 310 0 0.00
Thermocoagulation for cranial neuropathy 89 0 0.00
R/O cranioplasty plate 54 0 0.00
Posterolateral spinal decompression 
(costotransversectomy), with/without posterior fusion 
9 0 0.00
Posterior lumbar interbody fusion 14 0 0.00
Posterior complex cervical fusion with screws, plates 37 0 0.00
Peripheral nerve decompression 162 0 0.00
Pallidotomy/thalamotomy 105 0 0.00
Other cranial nerve operation including canthoplasty, 
balloon compression,alcohol injection 
61 0 0.00
Operations for syrinx 56 0 0.00
Open reduction dislocated spine (cervical – sacral) 53 0 0.00
Neurotomy/neurectomy (Frazier's operation) for cranial 
neuropathy 
61 0 0.00
Needle biopsy of vertebra  28 0 0.00
Microdiscectomy 48 0 0.00
Janetta procedure (microvascular decompression of 
cranial nerve) 
143 0 0.00
I/O ventriculo-atrial shunt 50 0 0.00
Frameless stereotactic E/O cerebral tumour 43 0 0.00
Foraminotomy  66 0 0.00
Facio-hypoglossal anastomosis 37 0 0.00
Craniotomy wrap aneurysm 24 0 0.00
Craniotomy exploration for tumour 21 0 0.00
Calf muscle stimulation** 51 0 0.00
** not recorded consistently in database 
 
Replacement in the model of operation groups by individual operations with the 
highest incidence of PE gave a significance test (-2LnL) of 222.1, more than 212.8 
for the model with operation group variables. P values for inclusion of these 
operation variables in the model are shown in the table below. 
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Table 3.4.6.1 - PE as outcome – logistic regression results –substitution of 
individual high-PE operations in the model 
 
Operation P Odds Ratio  
(95% C.I.) 
Lumbar spinal fusion  <0.001 4.04 ( 1.81 – 9.03 
Unplanned return to theatre for reopening 
craniotomy  
<0.001 3.47 (1.89 – 6.39) 
Partial excision cerebral tumour  <0.001 2.91 ( 1.57 – 5.39) 
Clipping cerebral aneurysm <0.001 2.74 ( 1.69 – 4.43) 
Insertion of external ventricular drain 0.053 1.99 (0.99 – 3.98) 
Craniotomy for evacuation spontaneous 
intracerebral bleed 
0.29 1.51 (0.71 – 3.20) 
Insertion ventriculo-peritoneal shunt 0.91 0.96 ( 0.45 – 2.05) 
 
This may be because most of the cases of PE are concentrated in the top seven 
operations, indicating that PE is associated with particular operations, rather than 
operations in general.  PE is less associated with particular diagnoses than with 
particular operations.  Partial excision of cerebral tumour is used particularly for 
excision of high grade primary brain tumours, because it is considered that with 
such invasive tumours, a total excision is not possible.  However, total excision 
would be a more usual procedure for menigiomas or secondary tumours, which are 
more likely to be circumscribed and more easily removed in toto. 
 
3.4.7 Summary of Logistic Regression Results 
 
A summary of the odds ratios for the logistic regression analysis is given in Tables 
3.4.7.1 and 3.4.7.2. 
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Table 3.4.7.1 - Effects of all factors on the occurrence of DVT, adjusted for    
                       length of stay, period, and age 
 
Factor Odds Ratio 
95% 
confidence 
limits 
Surgeon1(reference category for surgeons) 1.0  
Surgeon 2 0.99 0.63  - 1.56 
Surgeon 3 0.77 0.41 – 1.44 
Surgeon 4 1.99 1.01 – 3.90 
Surgeon 5 1.11 0.52 – 2.33 
Surgeon 6 1.17 0.54 – 2.52 
Surgeon 7 1.76 0.72 – 4.33 
Diagnostic group – tumours 2.19 1.53 – 3.14 
Diagnostic – vascular group 2.58 1.86 – 3.58 
Diagnostic - trauma group 1.48 1.06 – 2.07 
Diagnostic – spinal group 1.23 0.85 – 1.79 
Diagnostic groups – other (reference group for 
diagnostic groups) 
1.00 n.a. 
No operation (reference group for operations) 1.0  
Operations – tumour group 2.64 1.93 – 3.61 
Operations – vascular group 2.82 2.08 – 3.82 
Operations – trauma group 1.96 1.35 – 2.86 
Operations – spinal group 1.65 1.14 – 2.39 
Operations – other group 2.29 1.77 – 2.94 
Operations – angiography 3.34 0.94 – 11 90 
Notes: 
1. There is collinearity with time periods and surgeon, which may explain the non-
significance of six of the seven surgeons in predicting DVT. The only surgeon 
with a significant contribution to DVT is Surgeon 4, a vascular surgeon. 
2. Odds ratios for surgeons are not adjusted for diagnoses or operations 
3. Odds ratios for diagnoses are not adjusted for surgeon or operation.  A spinal or      
       “other” diagnosis is not associated with DVT; 
4. Odds ratios for operation are not adjusted for surgeon or diagnoses.  Excison of 
spontaneous intracerebral haemorrhage, papaverine angiography, excision of 
arteriovenous malformation, insertion of external ventricular drain and return to 
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theatre for reopening of craniotomy are all associated with DVT while barbiturate 
coma is not associated with DVT. 
 
Table 3.4.7.2 - Effects of all factors on the occurrence of PE, adjusted for 
length of stay, period, and age 
Factor Odds Ratio 
95% 
confidence 
limits 
Surgeons Not significant 
(collinearity 
with period) 
 
Diagnosis 1- anterior communicating artery aneurysm 3.55 1.93 – 6.51 
Diagnosis 2- spinal trauma 2.33 1.28 – 4.25 
Diagnosis 3 – middle cerebral artery aneurysm 2.60 1.28 – 5.29 
Diagnosis 4 – meningioma 2.04 1.05 – 3.95 
Diagnosis 5 – cerebral infarct on admission 3.12 1.34 – 7.28 
Operation 1- reopen craniotomy 3.47 1.89 – 6.39 
Operation 2 – insertion external ventricular drain 1.99 0.99 – 3.98 
Operation 3 – spinal fusion 4.04 1.81 – 9.03 
Operation 4 –clip cerebral aneurysm 2.74 1.69 – 4.43 
Operation 5 – insertion of ventriculoperitoneal shunt 0.96 0.45 – 2.05 
Operation 6 – craniotomy for partial excision tumour  2.91 1.57 – 5.39 
Operation 7 – excision spontaneous intracranial 
haematoma 
1.51 0.71 – 3.20 
 
3.4.8  Conclusion:  
The results of the multivariate logistic regression confirm the results of the univariate 
analysis of predictors of DVT.  After adjustment for length of stay, period and age, 
vascular surgery is the strongest predictor for DVT (OR = 2.82, 95% CI: 2.08 – 3.82, 
χ2 = 43.91, P <0.01); vascular diagnosis is the strongest diagnosis predictor of DVT 
(OR = 2.58, 95% CI : 1.86 – 3.58, χ2 = 39.45, P <0.001); Surgeon 4 is the only 
surgeon who is a significant predictor of DVT (OR = 1.99, 95% CI: 1.01 – 3.90, χ2  
not calculable).  There is no effect of sex.  An effect of season cannot be 
demonstrated on either DVT or PE. 
For PE, after adjustment for length of stay, period and age, individual operations 
provided the best model.  Spinal fusion was the strongest predictor of PE (OR = 
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4.04, 95% CI: 1.81 – 9.03).  Anterior communicating artery aneurysm was the 
diagnosis most highly associated with PE (OR = 3.55, 95% CI: 1.93 – 6.51).  No 
surgeon was associated with increased incidence of PE, although Surgeon 4 (OR = 
3.15, 95% CI: 1.15 – 8.67) and Surgeon 7 (OR = 4.81, 95% CI: 1.32 – 17.52) were 
close. 
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CHAPTER 4 -  DISCUSSION 
4.1 LIMITATIONS 
The results of this study need to be understood with knowledge of its limitations, 
which include the following: 
 
 The retrospective nature of the cases added before 1982 could make the first six 
years of the analysis from 1976 to 1999 (e.g. Chapter 3.1), and the first three 
years of the analysis from 1979 to 1998 (e.g. the logistic regression analysis) 
less valid than the later years.  Lack of access to the medical records of 
admissions from the early years would make the data less reliable.  It is more 
likely that DVT and PE be underreported in the earliest years of the database.  
However a review of Fig. 3.1.1 shows that this does not change the general 
nature of the findings that there has been a considerable rise in the incidence of 
both DVT and PE since 1983.    
 The exclusion of about 0.5% of potential admissions from the database, 
mentioned in Chapter 2.1 adds a small error to the results, both to the 
denominator and the numerator.   
 Lack of follow-up.  The varied length of stay imposes an arbitrary follow-up 
period for these patients.  Lack of outpatient follow-up mentioned in Chapter 
1.1.3 means that some cases of DVT and PE occurring as a result of the 
inpatient stay at RNSH will be missed.  This will have the effect of falsely 
lowering the incidence of DVT and PE in this study.  As LOS declines in the later 
years of the study, this effect will be enhanced, but adjusted for by the LOS 
variable in the logistic regression analysis. 
 Measurement error in the diagnosis of DVT and PE, which has changed over the 
twenty-year period described Chapter 1.2.5 on p.12.  This would tend to falsely 
lower the incidence, particularly of DVT, in earlier years, since diagnostic 
procedures have improved in accuracy the most over time.  This is further 
discussed on p.82.   
  
 
 
 
 
 
4.2 OVERALL RESULTS 
 
 80
The main findings of this study are - 
4.2.1  A low rate of DVT and PE 
The overall incidence in this study of DVT at 1.8% and PE at 0.74% compare well 
with published figures for unscreened neurosurgery patients, with and without 
operation, of 2.3% for DVT and 1.8% for PE (Black & Baker MF 1986).  If operated 
patients only are included, the rate of DVT in this study overall is 2.9% and of PE 
1.2%.  Even in the most recent period of 1994-98, the rates for this study are still 
only 3.6% (DVT) and 1.2% (PE) respectively for all patients, with 5.9% (DVT) and 
1.7% for PE in operated patients.  The low incidence in the present study is largely 
because its cases are identified using clinical criteria.  A small proportion would 
have been found by screening; valid comparison with the published literature can 
only be undertaken with non-screening studies.  Looking for DVT in those patients 
considered to be at risk in the current study has been carried out selectively since 
about 1991.  This may contribute in a small way to the rise in incidence of DVT since 
this time.  Routine screening of all surgical patients, such as used in many published 
articles (Agnelli, Piovella, et al. 1998) would reveal many more venous thromboses, 
largely “silent” or calf vein, and not showing symptoms or signs.  These articles 
quoted about a 30% DVT rate in the days before prophylaxis and treatment were 
considered appropriate treatment.  In favour of routine screening is that it might 
identify those discharged with silent vein thromboses who are at risk of re-
presenting with major DVT or PE, but the resources are not available for such a 
task.  However, since this study was completed, and because of increased 
awareness brought about by this study and by morbidity and mortality meetings, 
post-operative vascular patients at RNSH are now screened for DVT by duplex scan 
within 7 days of surgery.  Reliable numbers of patients readmitted with DVT or PE 
resulting from a silent undiagnosed thrombosis at a previous admission are not 
available, because patients can re-present to other hospitals and other departments 
within RNSH.  Follow-up by the surgeons involved does not identify this as a 
common event. 
The lower rates in this study may also reflect measurement error in any of the 
studies compared, patient selection differences, presence or absence of prophylaxis 
or treatment, lack of reporting in the patient record or in the database, or good 
prophylaxis and inpatient care in the Neurosurgery Department.  Some studies 
include elective patients only; some operated patients only. 
Comparison with other studies reveals that the data in the present study is valid.  
Despite the lower rates in the present study, the order of magnitude is similar to 
other studies.  Differences observed between clinical groups within the present 
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study and that of Bostrom, Holmgren et al (1986) show that the accuracy of the 
database is sufficient to make valid comments about clinical practice.  
4.2.1.1  DVT, PE and Mortality 
The greater incidence of DVT than of PE is to be expected, because not all cases of 
DVT progress to PE, but some cases of PE arise without prior diagnosis of DVT.  
The greater incidence of death in those patients with PE does not necessarily imply 
causation.  PE may be the cause of death, as found at post-mortem, but it is known 
that fatal illness is more likely to have an incidental occurrence of PE. 
The fall in death rate seen in Fig. 3.1.1 runs concurrently with the rise in DVT rate.  
This is likely to be a coincidental finding. The decline in trauma admissions during 
this period, shown in Table 3.2.6.1, does not contribute to the fall in death rate, 
which actually increases over the period from 10% to 12% of trauma admissions 
(see Table 3.1.1).  Initiatives such as Random Breath Testing and other road traffic 
controls were concurrent with the decline in road trauma admissions over the period 
recorded in the database (McDermott & Strang, 1978, McDermott 1978).  
Improvements in clinical management of all patients would have contributed to the 
fall in death rate.  
Table 3.1.1 shows that although death rates have fallen over time for tumour and 
vascular patients, they have risen for trauma and spinal patients in this department.  
The fall in death rate for vascular cases should be read in the context of the 
department acting increasingly as a tertiary referral centre for difficult vascular 
cases.  As the death rate for vascular patients was as high as 15% in 1979-83, the 
fall to 11% is encouraging.   
4.2.1.2 Comments on predictors 
Age.  The fact that patients, as part of the general population, are living longer than 
they did twenty years ago, increases their risk for DVT and PE.  The cause of the 
increase and decline in rate of DVT over age groups shown in Figure 3.2.2 is not 
known.  The rate for PE follows the rate for DVT.  There appear to be two humps in 
each curve of this graph, implying two mechanisms at work: one with a peak at ages 
30-39 years, the second with a peak at 70-79 years.  The extra variable agegp, 
created to account for the non-linearity in the age by DVT/PE curves, was 
insignificant when run in the logistic regression equation, indicating that this decline 
is not important.  It is possible, however, that the decline reflects the fact that the 
older patients are not vasculopaths.  In other words, the patients most likely to 
succumb to vascular diseases such as heart disease and stroke, and also DVT or 
PE, are no longer well represented in the population of eighty-year olds.  
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Sex: the results of univariate and logistic regression analysis, which show no 
difference in incidence in the rate of DVT and PE between the sexes, are in 
agreement with the accepted literature.  
 
Season: No statistical confirmation of the reported fluctuation was found.   
 
LOS: The rise in DVT rate to 14% for patients staying over two months, followed by 
a decline to about 3% for patients staying longer, may reflect the fact that most 
patients who have several risk factors for acquiring DVT or PE are likely to have 
done so by 80 days’ hospital stay.  The two peaks for PE in Fig. 3.2.5 suggest that 
there may be different mechanisms at work in the aetiology of PE.  It is possible that 
the first hump represents DVT/PE due to surgery, which is usually not long after 
admission.  The second hump may represent DVT/PE acquired because of 
prolonged immobility in bed, in patients with stroke, subarachnoid haemorrhage or 
repeated visits to the operating theatre.  The second hump may reflect 
haematological effect on vessels of prolonged confinement to bed.  The significance 
of the added variable, LOSgp, to account for the non-linearity of LOS in the model, 
shows that the decline in incidence of DVT for the longest (>80 days) LOS is a valid 
feature.     
 
Surgeon: The effects of surgeon are not as strong as those for diagnosis or 
operation.  If there were no collinearity between these three variables, these effects 
may be revealed to be by association with the surgeons’ preferred operations. This 
is particularly so for Surgeons 3 and 4, whose work is most highly specialised.  
Surgeon 7 has very small numbers, which may not be large enough to be 
meaningful.  A link is provided by Surgeon 3, whose practice spans the time of the 
notable change in pattern of DVT and PE incidence around 1992 (Figs. 3.1.1, 
3.2.8.1and 3.2.8.2).  The DVT incidence for Surgeon 3 is similar to that of Surgeon 2 
before 1992.  The DVT rate increases for Surgeon 3 as the new surgeons 
commence practice.  For PE, though, Surgeon 3’s rate is greater than Surgeon 2 in 
1992, so the increase after 1992 in PE rate may be totally confounded with surgeon.  
Certainly, Surgeon 3’s practice has been increasingly focussed on major spinal 
surgery, which has a high PE incidence in this study (Table 3.2.7.2).   
 
Diagnosis: There is a significant difference between incidence of DVT in patients 
with meningioma and patients with high-grade glioma, either operated or all 
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discharges.  Bostrom et al (1986) reported DVT rates for subgroups of patients – 
17% in patients with intracranial malignancy; 29% in patients with intracranial 
vascular disease, 8% in patients with spinal diagnoses, compared to 10-13% 
overall.  Bostrom’s patients were given heparin or calf stimulation with Dextran as 
prophylaxis against DVT.  Although his numbers are small, the relative increases in 
DVT incidence that Bostrom notes for some groups are reflected in the present 
study (Table 3.4.2.1). 
 
Surgical group: It is unfortunate that it is not possible to give odds ratios for 
operations adjusted for all factors including vmo (surgeon) and diagnosis, because 
of collinearity.   
 
4.2.2 A six-fold rise in the rate of DVT over the last twenty years 
There is a difference in the rate of increase over time between DVT and PE.  The 
steeper rise in the DVT curve over time (Fig. 3.1.1) suggests that some factor which 
contributes to DVT more than to PE is contributing to the steeper rise. As mentioned 
above, increased screening rates for at-risk patients may partly explain this. The 
introduction of duplex scanning at RNSH in the early 1990s made it easier to identify 
DVT, finding more cases than during the previous period, including distal and “silent” 
thromboses.  It was then possible to treat these patients to prevent the formation of 
DVT and progression to PE.  Alternatively, progression of DVT to PE is being more 
effectively controlled than de novo formation of DVT.  However, this does not 
explain the doubling in rate of PE over the twenty years of the study. 
 
From logistic regression analysis the increase in DVT rate is shown to be associated 
with increasing age, length of stay (which has declined over the last twenty years), 
vascular surgeon, vascular, tumour and trauma diagnoses and all operations.  It is 
shown not to be associated with spinal, peripheral nerve, non-tumour cranial nerve 
or infectious diagnoses.  That is, after allowing for LOS, age, and period of time, 
most operations, some diagnoses and one surgeon have significant association with 
DVT.  This implies that change in surgical practice has some input into the equation.  
This correlates with the known predictors of DVT, although a strong relationship of 
DVT with cerebrovascular surgery has not been documented, except by Bostrom, 
Holmgren , et al. (1986). 
Table 3.2.7.1 indicates the sustained rise in the number of vascular surgery 
procedures.  This rise may be due to the complex management requirements of 
cerebro-vascular surgery patients.  Such patients may have had a subarachnoid 
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haemorrhage and are often unconscious and paretic.  They are routinely given a 
strict regime of medication used prophylactically against ischaemia which requires 
their stay in the intensive care ward for at least three weeks.  It is possible that this 
limits the mobility of those patients who might otherwise be more active, minimising 
the risk of stasis of blood in their legs.  Stay in the Intensive Care ward has only 
been recorded for the last five years in the Neurosurgery database, so it has not 
been studied in relation to DVT and PE incidence.  Over the last six years more 
interventional postoperative management such as papaverine angiography and 
thiopentone coma has been introduced for vascular patients.  Some patients may 
undergo ten angiographies during an admission.   It is not possible to show a 
relationship between angiography and DVT through regression analysis because 
the time span since angiography was recorded is not long enough in this study.  
However, crude percentages in Tables 3.4.3 and 3.4.5 indicate rates of 20% for 
DVT and 5% for PE in patients undergoing these procedures.  Patients who have 
had an intracerebral bleed may develop hydrocephalus, needing CSF shunting 
procedures.  Such procedures carry an 8% risk of DVT.  They often require insertion 
of an external ventricular drain, which carries a 10% risk of DVT.  These procedures 
may be seen as markers of reduced cerebral function and prolonged LOS.   
4.2.3  A doubling of the rate of PE   
There is convincing but less strong evidence gained from the database that there 
has been a doubling of the incidence of PE over the last twenty years, from 0.6 to 
1.2%.  PE is found to be most highly associated with aneurysm, stroke and spinal 
trauma and with operations, notably spinal fusion, re-opening of craniotomy, and 
craniotomy for partial excision of tumour.  This operation is most commonly 
performed for high-grade malignant tumours, and for invasive meningiomas where 
extended operative time is required.  There is borderline association with 
meningioma per se, and a marginal effect of two surgeons.     
The bimodal distribution for PE seen in Fig. 3.2.5, (DVT and PE by LOS) implies a 
different mechanism at work for PE than simple evolution from DVT, which shows a 
more Normal distribution.  Although the six-fold increase in diagnosis of DVT has not 
translated into a similar increase for PE, the cause for the doubling of PE rate is 
unexplained.  It is possible, though unlikely, that fewer PE were diagnosed in the 
earlier periods.  Table 3.2.8.2 shows that Surgeon 3, whose practice spans the low-
PE and high-PE periods, commenced with a higher PE rate than Surgeon 2 during 
and continued thus during the same period.  This may reflect his interest in spinal 
surgery, which carries a greater risk of PE than did Surgeon 2’s operations.  Various 
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vascular and tumour diagnoses and reopening of craniotomy are high predictors of 
both DVT and PE, but spinal trauma and surgery feature only with PE.  This also 
indicates a different mechanism for its aetiology.  
 
4.3  OTHER FACTORS WHICH CAN INFLUENCE THE RATE OF DVT 
AND PE WHICH THE PRESENT ANALYSIS DOES NOT REVEAL 
 
Predictive factors not recorded systematically in the whole database include sepsis 
and limb weakness (paresis).  The incidence of DVT and PE is noted for patients 
with septic conditions on admission (Tables 3.4.2, 3.4.3, 3.4.5, 3.4.6), who make up 
a small proportion of the total admissions.   
Sepsis as a complication is not easy to record because of its subjective nature and 
is not included in the analysis.  
Paresis is a frequent complication in patients with vasospasm.  Patients undergoing 
cerebrovascular surgery such as aneurysm clipping may develop spasm of the 
cerebral arteries which causes ischaemia and infarction of brain tissue.  The 
resultant neurological deficit may be apparent as decreased level of consciousness 
or paresis of one or more limbs, a well-recognised predictor of DVT (Gibberd, Gould 
et al. 1976).  Over the last eight years the database records clinical vasospasm 
and/or infarct in 18% of DVT cases and 17% of PE cases.  It is not known, however, 
whether these patients had a limb paresis.   
Prophylaxis.  Use of calf compression devices, calf stimulators and graded 
compression stockings is not recorded in the database, but it is known that they 
have not been consistently used throughout the last twenty years in neurosurgery 
patients, as discussed in Chapter 4.4.2.  Treatment and prophylaxis for DVT and PE 
given to patients over the last twenty years will obviously have a bearing on the 
rates of DVT and PE.  Some of these variables, which change with styles of 
management over time, may be considered to be accounted for in the “period” 
variables, but some will probably be “noise” or error in the logistic regression 
analysis.    
 
4.4  ISSUES IN THE MANAGEMENT OF DVT AND PE 
 
4.4.1 Changes in management over time 
It is interesting to view Fig. 3.1.1 with reference to changes in measurement and 
management of DVT in the four periods used in the present analysis.  1979-83 
represents a period when low-dose heparin and the pneumatic leg compression 
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device were introduced for prophylaxis of DVT, and FUT and Doppler scanning were 
introduced for the identification of DVT.  For neurosurgery patients caval filters were 
preferred for treatment.  Some were given IV heparin.  Patients were on prolonged 
bedrest after procedures where they would be mobilised early now.  In 1984-88 
Duplex scanning was introduced at RNSH for detection of DVT, in 1989-93 low 
molecular-weight heparins such as enoxaparin were introduced for prophylaxis and 
treatment of DVT. 
From 1976 until 1990, the general neurosurgery ward at RNSH was under the 
nursing direction of one person.  There were only two surgeons admitting patients, 
providing an era of stability in patient care.  Within the three years after 1990, there 
were several changes of nursing management and the addition of three new 
surgeons.  This may have had some influence on the rates of DVT and PE. 
 
4.4.2  Risk Management  
Prophylaxis and treatment in this department is conducted using best practice 
principles, but there has been no rigid protocol in the past because of the risk of 
haemorrhage and neurological damage.  Surgeons were aware of different methods 
of prophylaxis, diagnosis and treatment, and cases were individually assessed for 
prophylaxis and treatment. 
The present study reveals groupings originating in the Neurosurgery Department’s 
database which can be used to confirm and refine gradings for new admissions for 
risk of DVT and PE.  Prophylaxis can be tailored to these groupings. The 
identification of a relative risk for DVT, adjusted for age, length of stay and period, 
for vascular surgery patients of 2.80, compared with no surgery suggests that 
considerable vigilance is required for these patients.  The same is true for the other 
high-risk patient categories, such as tumour and spinal patients. 
4.4.3  Other management issues 
 The difficulty in prescribing anticoagulants for neurosurgery patients.  Although 
the risk of haemorrhage with the use of anticoagulants is reportedly not high 
(Cerrato, Ariano, et al. 1978) the consequences of an intracranial bleed can be 
catastrophic.   
 There may not be sufficient compliance with orders for compression stockings, 
calf compressors or calf stimulators.  
 Costs of effective pneumatic calf compression devices prohibit routine 
availability in this hospital. 
 
4.5  SUMMARY AND RECOMMENDATIONS 
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This study confirms the figures reported in the literature for rates and predictors of 
DVT and PE in general neurosurgical populations.  The marked rise revealed in the 
incidence of DVT is probably due to increased ease of availability of duplex 
scanning, increased high-risk surgery, complex management protocols for some 
patients, and changes in ward management and staffing.  It identifies cerebro-
vascular patients, who have not been widely studied for DVT and PE, to be at high 
risk. The doubling of PE rate is not easily explained but is highly associated with 
spinal fusion.  In spite of these rises, it is noted that mortality from PE has been 
contained. 
 
This database is thus a useful tool for identifying high-risk patients in the RNSH 
population.  However it is not a effective study design for assessing the influence of 
mechanical and pharmacological prophylaxis on the incidence of DVT or PE, 
because these measures were not recorded systematically in the database. 
 
The rise in rate of DVT has incurred the use of expensive LMWH treatments which 
are used increasingly in these patients for treatment.  More vigilant and widespread 
use of mechanical prophylactic methods might be just as effective in controlling DVT 
and PE. 
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